Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20090259092 A1
Publication typeApplication
Application numberUS 12/467,762
Publication dateOct 15, 2009
Filing dateMay 18, 2009
Priority dateJun 22, 2006
Also published asUS20140235932
Publication number12467762, 467762, US 2009/0259092 A1, US 2009/259092 A1, US 20090259092 A1, US 20090259092A1, US 2009259092 A1, US 2009259092A1, US-A1-20090259092, US-A1-2009259092, US2009/0259092A1, US2009/259092A1, US20090259092 A1, US20090259092A1, US2009259092 A1, US2009259092A1
InventorsJason W. Ogdahl, Robert E. Lund, Jessica L. Roll, Kelly Ann Chapman, John Fritz Otte
Original AssigneeOgdahl Jason W, Lund Robert E, Roll Jessica L, Kelly Ann Chapman, John Fritz Otte
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Adjustable Sling and Method of Treating Pelvic Conditions
US 20090259092 A1
Abstract
Systems for providing support within the pelvic region of a patient. The systems can include an elongated incontinence sling having a central support portion adapted to be positioned to support any one of the urethra or anus, and a sling tension adjustment mechanism operatively attached to the elongated sling. The sling tension adjustment mechanism can include a plunger device adapted for traversal within an interior of the housing, and an inflatable bladder provided within the housing to selectively control traversal of the plunger. Alternatively, the adjustment mechanism can include a bobbin device within the housing and one or more retention devices to selectively restrict unwinding of a suture from the bobbin device.
Images(40)
Previous page
Next page
Claims(21)
1. A system for providing support within the pelvic region of a patient, comprising:
an elongated sling having a sling length, a central support portion positionable to support the urethra of the patient, and first and second sling end portions extendable through body tissue;
a tension adjustment assembly operatively connected with the elongated sling to selectively adjust the sling length, the tension adjustment mechanism at least partially contained within a housing and having;
a plunger device adapted for traversal within an interior of the housing; and
an inflatable bladder to selectively control the traversal of the plunger device within the interior of the housing.
2. The system of claim 1, wherein the plunger device includes a rod portion and a head portion.
3. The system of claim 2, wherein the inflatable bladder is provided within the interior of the housing for selective abutable contact with the head portion of the plunger device.
4. The system of claim 1, wherein the plunger device includes a body portion having a cavity defined therein such that the inflatable bladder is at least partially disposed within the cavity.
5. The system of claim 4, wherein the plunger device further includes a head portion.
6. The system of claim 1, further including an inlet in fluid communication with the inflatable bladder.
7. The system of claim 1, further including a housing inlet in fluid communication with the interior of the housing.
8. A system for providing support within the pelvic region of a patient, comprising:
an elongated sling having a sling length, a central support portion positionable to support the urethra of the patient, and first and second sling end portions extendable through body tissue;
a tension adjustment assembly operatively connected with the elongated sling to selectively adjust the sling length, the tension adjustment mechanism at least partially contained within a housing and having;
a bobbin device provided within an interior of the housing and having a length of a suture wrapped therearound, with at least one end of the suture operatively connected to the elongated sling; and
a retention device provided within the interior of the housing to selectively restrict unwinding of the suture from the bobbin device.
9. The system of claim 8, wherein the bobbin device includes a generally transverse flange portion to selectively restrain a portion of the suture to restrict unwinding of the suture from the bobbin device.
10. The system of claim 9, wherein the flange portion at least partially constructed of a resilient material.
11. The system of claim 8, further including at least one member provided within the interior of the housing to facilitate in selectively restricting unwinding of the suture from the bobbin device.
12. The system of claim 11, wherein the at least one member is a biasing member.
13. The system of claim 12, wherein the biasing member is a spring.
14. The system of claim 11, wherein the at least one member selectively restrains a portion of the suture to restrict unwinding of the suture from the bobbin device.
15. The system of claim 8, wherein the bobbin device further includes a central bore defined therein, and the housing further includes a recess axially alignable with the central bore.
16. The system of claim 15, further including a locking member disposable within the central bore and the recess to selectively restrict unwinding of the suture from the bobbin device.
17. The system of claim 8, further including a plurality of detents defined in a generally transverse flange portion of the bobbin device.
18. The system of claim 17, further including a member adapted to engage one or more of the plurality of detents to selectively restrict unwinding of the suture from the bobbin device.
19. The system of claim 8, further including a set screw operatively provided with the housing and the bobbin device to selectively restrict unwinding of the suture from the bobbin device.
20. A method of providing support within the pelvic region of a patient, comprising:
providing an elongated sling having a sling length, a central support portion positionable to support the urethra of the patient, and first and second sling end portions extendable through body tissue
providing a tension adjustment assembly operatively connected with the elongated sling to selectively adjust the sling length, the tension adjustment mechanism at least partially contained within a housing;
providing a plunger device adapted for traversal within an interior of the housing;
providing an inflatable bladder within the housing; and
adjusting fluid volume within the inflatable bladder to selectively control the traversal of the plunger device within the interior of the housing.
21. A method of providing support within the pelvic region of a patient, comprising:
providing an elongated sling having a sling length, a central support portion positionable to support the urethra of the patient, and first and second sling end portions extendable through body tissue
providing a tension adjustment assembly operatively connected with the elongated sling to selectively adjust the sling length, the tension adjustment mechanism at least partially contained within a housing;
providing a bobbin device within an interior of the housing, the bobbin device having a length of a suture wrapped therearound, with at least one end of the suture operatively connected to the elongated sling; and
providing a retention device within the interior of the housing; and
adjusting the retention device to selectively restrict unwinding of the suture from the bobbin device
Description
RELATED APPLICATIONS

This application is a Continuation-In-Part of U.S. patent application Ser. No. 12/305,874 filed Dec. 19, 2008, which claims priority to PCT Application No. PCT/US2007/014533 filed Jun. 22, 2007, which in turn claims priority to U.S. Provisional Application Ser. No. 60/805,544 filed Jun. 22, 2006 and U.S. Provisional Application Ser. No. 60/806,664 filed Jul. 6, 2006; this application also claims priority to and the benefit of U.S. Provisional Application Ser. No. 61/054,011 filed May 16, 2008 and U.S. Provisional Application Ser. No. 61/054,050 filed May 16, 2008; whereby the entire contents of each of the above-identified applications and disclosures are incorporated herein by reference.

TECHNICAL FIELD OF THE INVENTION

The present invention pertains to improved methods and apparatus providing support to a portion of the urethra, rectum or anus to alleviate urinary or fecal incontinence and, particularly, to elongated slings having mechanisms for selectively adjusting the tension applied through the sling to the body tissue.

BACKGROUND OF THE INVENTION

Urinary incontinence is a condition characterized by involuntary loss of urine, beyond the individual's control, due to the loss or diminution of the ability to maintain the urethral sphincter closed as the bladder fills with urine. Male or female stress urinary incontinence (SUI) occurs when the patient is physically or emotionally stressed. Such patients may also experience urge incontinence.

Fecal incontinence is a condition characterized by involuntary defecation or passage of feces through the anal canal due to injury to or weakness of one or more of the internal anal sphincter, the external anal sphincter, and the levator ani.

Implantable urethral and anal prosthetic sphincter systems have been disclosed in the prior art to treat incontinence that comprise an inflatable balloon that is either pillow or cuff shaped, a balloon reservoir/pressure source filled with a fluid, a pump, and interconnecting tubing. The balloon is implantable beneath or surrounding the urethral tract (at or near the bladder neck in female patients) or around the anal sphincter and is coupled through tubing to the balloon reservoir/pressure source and pump that are implanted subcutaneously. The pump may be manually actuated to inflate the balloon, which in turn compresses the urethral tract and prevents incontinence. The balloon may be deflated to allow voiding. Examples of such prosthetic sphincter systems are disclosed in U.S. Pat. Nos. 4,222,377, 4,571,749, and 5,562,598, and one such system comprises the AMS-800 Urinary Control System available from American Medical Systems, Inc.

Urethral tapes or slings have been developed that are implanted in a urethral sling procedure in which the urethral sling is inserted beneath the urethra and advanced in the retro pubic space, perforating the abdominal fascia. In one procedure, peripheral or end portions of the elongated urethral sling are affixed to bone or body tissue, and a central support portion of the elongated urethral sling extends under the urethral or bladder neck to provide a platform that compresses the urethral sphincter, limits urethral distention, and pelvic drop, and thereby improves coaptation. Elongated “self-fixating” slings have also been clinically introduced for implantation in the body that do not require that the end portions be physically attached to tissue or bone and that rely upon tissue ingrowth into sling pores to stabilize the sling as disclosed, for example, in commonly assigned U.S. Pat. Nos. 6,382,214, 6,612,977, 6,641,524, 6,648,921, 6,652,450, 6,702,827, 6,802,807, and 6,911,003 and publications and patents cited therein.

The above-described slings comprise a central portion that is adapted to support the urethra, two end portions bracketing the support portion, a protective sheath or sheaths encasing at least the end portions, and connectors at the ends of the sling. Various ways of attaching a sleeve end and sling mesh end to a connector are detailed in the above-referenced '450 patent, for example. Further ways of attaching sling ends to sling implantation tools are disclosed in U.S. Patent Application Publication Nos. 2004/0087970, 2005/0245787, and 2005/0250977. The sling implantation tools are employed to form tissue pathways extending from a vaginal incision to two abdominal skin incisions and to draw the sling end portions through the pathways to dispose the sling free ends out of the skin incisions and the central portion around the urethra. The connectors are detached from the sling ends, and the sheaths are drawn out of the skin incisions, allowing the incisions to be closed.

Sling tension is typically adjusted at implantation sufficiently to take up any slack in the sling and impart at least a degree of increased tension to the urethra with the bladder empty. A surgical instrument may be placed between the sling central portion and the urethra, the sling ends drawn to tension and fully close the urethral tract, and the instrument withdrawn so that the uethra is relaxed sufficiently to function. Alternative tension adjustment mechanisms that may be employed during implantation are disclosed in the above-referenced commonly assigned '827 and '921 patents.

Typically, such urethral tapes or slings are fabricated of a loose weave sling fabric or mesh that acutely engages tissue and encourages tissue ingrowth along the pathway through mesh pores to achieve chronic stabilization or “self-fixation. Tissue ingrowth takes about 2-3 weeks in the typical patient in the absence of any significant intentional or unintentional movement of the mesh. During this post-operative time, the patient monitors the degree of success achieved in ameliorating leakage and any discomfort that might occur if the applied tension is so high as to unduly slow voluntary urination.

If any such problems occur, it may be necessary to reopen the incisions to access and pull on the sling ends to tighten the sling central portion around the urethra or to reopen the vaginal incision to pull on the sling central portion to loosen the sling central portion around the urethra. Several approaches have been taken to simplify or reduce the need for such post-operative adjustments.

One tension adjustment complication arises from the fact that the loose weave sling mesh inherently stretches and elongates when tension is applied at the ends or central support portion to overcome resistance of the tissue bearing against the sling mesh along the tissue pathway. It is difficult to judge just how much tension to apply to achieve adequate tightening or loosening in the central support portion. In one approach to overcoming this complication disclosed, for example, in the above-referenced '450 patent, an elongated repositioning means, e.g., an elongated inextensible tensioning member, is incorporated extending in or along the sling mesh from near the sling ends to or through the sling central portion. Tension applied to the repositioning means is transmitted along the length of the sling so the sling mesh does not substantially stretch during initial positioning and any repositioning during the acute healing phase.

In another approach disclosed, for example, in U.S. Patent Application Publication 2006/0058574 (FIGS. 4 a-4 f), an expandable member or container is incorporated on or in the sling central support portion that can be inflated or deflated with bulking agent to apply more or less tension to the urethra. As stated therein, optionally, the container has a touchable internal valve element to permit the surgeon to palpate the area prior to injecting or removing the bulking agent. Alternatively, the bulking agent may be injected and removed via a two-way external port. When a bulking agent is injected into the container, the tissue between the mesh and urethra will expand. This results in two effects; a simple vertical lifting due to expansion and a vertical lifting due to stretching the outside of the mesh. A suitable bulking agent may be water or saline. A similar approach is disclosed in U.S. Pat. Nos. 4,019,499 and 6,786,861.

Other approaches that enable increasing tension of the sling central portion against the urethra involve shortening the lengths of the sling end portions as described, for example in the above-referenced, commonly assigned '921 patent. Mesh folds are formed in the sling end portions using filaments that extend through vaginal incisions externally of the body. Depending on the embodiment, the mesh folds can be released to decrease sling tension or be tightened to increase sling tension by pulling on the filament ends following the initial implantation procedure. In other embodiments, filaments are extended substantially through the lengths of the sling end portions and extend from the vaginal incisions. The filaments may be gripped and pulled to tighten the mesh in the sling end portions to increase overall sling tension.

In still another approach disclosed, for example, in U.S. Patent Application Publication 2006/0058574 (FIGS. 5 a-5 c), the mesh sling or tape is further modified to include a mechanical adjustment means to adjust the length of the tape in the end portions on either side of the central portion after the tape has been implanted in the tissue pathways. The mechanical adjustment means incorporate a tie-wrap mechanism or sutures and one-way suture retaining devices of the type disclosed in U.S. Pat. No. 5,669,935 located along the tape on either side of the central portion. In each case, one suture end is affixed to the tape and extends along it and through a suture retaining device affixed to the tape closer to the central portion. The sutures or tie-wrap are not tensioned at implantation, and the tie-wrap or suture free ends extend through the vaginal incision. If the tension on the urethra is too light as determined during the acute healing phase, the surgeon may grasp and pull on the tie-wrap or suture free ends to shorten the lengths of the tape end portions and thereby increase sling tension. The exposed suture or tie-wrap ends may be severed during chronic implantation.

In yet another approach, tape or sling ends or the end of a tensioning cable coupled to a urethral support mechanism are coupled to an adjustment mechanism that is chronically implanted subcutaneously and can be accessed to adjust sling tension. See, for example, commonly assigned U.S. Pat. No. 4,969,892 and further U.S. Pat. Nos. 5,474,518 and 6,117,067 and the REMEEX® readjustable sling by Neomedic, Intl. (www.remeex.com). Ratchet or gear adjustment mechanisms that are accessed using a driver inserted through the skin and thereby rotated to increase or decrease sling tension are disclosed in the '892 and '518 patents. An inflatable/deflatable elastic chamber, adjustment mechanism that incorporates a fill port that is penetrable by a syringe needle advanced through the skin is disclosed in the '067 patent. The adjustment forces are applied to the sling ends and must be transmitted through the sling to effect any change in tension along the sling central portion adjacent the urethra.

Further sling tension adjustment mechanisms and techniques involve adding tensioning filaments to the sling free ends and extending the elements through the skin incisions and into engagement with buttons or pads implanted subcutaneously engaging a muscle or rectus fascia layer and/or having tissue engaging elements or anchors along the filament or at the sling ends that engage subcutaneous tissues as disclosed, for example, in U.S. Pat. No. 6,911,002 and in U.S. Patent Application Publication Nos. 2005/0004576 and 2006/0089525.

Although effective in alleviating SUI, further improvements in urethral and anal slings to post-operatively adjust tension applied to the urethra and anus are desirable.

SUMMARY OF THE INVENTION

The preferred embodiments of the present invention incorporate a number of inventive features that address the above-described problems that may be combined as illustrated by the preferred embodiments or advantageously separately employed.

The present invention involves improvements in an elongated incontinence sling, or simply sling, comprising a central support portion and end portions extending from the central portion to sling ends. Herein, use of the term sling or the expression “incontinence sling” without further qualification shall embrace urethral slings adapted to be placed through a tissue pathway disposing the central support portion between the urethra or bladder neck (hereafter collectively referred to as the urethra for convenience) and the vaginal wall to alleviate urethral incontinence and fecal slings adapted to be placed through a tissue pathway disposing the central support portion inferior to the anus, the anal sphincter or the lower rectum (hereafter collectively referred to as the anus for convenience) to alleviate fecal incontinence. Certain embodiments employ tensioning filaments or lines or sutures that are referred to as sutures for convenience.

In accordance with the present invention, such slings are improved to enhance post-operative sling adjustment of the tension applied to the urethra or anus to enhance efficacy and patient comfort. Several categories of the invention are disclosed herein. The various embodiments disclosed herein are applicable to both males and females, to address issues of incontinence in both, to address issues of prolapse repair in female and perineal floor descent, as well as fecal incontinence in both. Also surgical techniques such as forming suprapubic, retropubic, transobturator, inside out, outside in tissue pathways between two skin incisions, or a tissue pathway formed from a single incision through the vagina or perineal floor (in male or female patients) are also contemplated for passage of a sling therethrough.

In various embodiments, sling tension adjustment mechanisms join separate sling pieces forming part of the sling mesh with the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing. Various adjustment actuators and techniques are employed to adjust the sling tension adjustment mechanisms to decrease or increase the adjustment spacing between the sling intermediate ends to thereby shorten or lengthen, respectively, the overall length of the sling end portions and to thereby increase or decrease, respectively, the tension applied by the central support portion to the urethra or anus. The sling tension adjustment mechanisms are disposed along the sling end portions so as to be disposed at tissue pathway locations that are proximate the patient's skin to enable application of the external adjustment actuator against the skin or through the skin and underlying tissues to operate the sling tension adjustment mechanisms.

In one embodiment, sutures are threaded back and forth through mesh pores adjacent the intermediate ends and across the respective adjustment spacings of each sling end portion. The suture ends are adapted to be extended through the skin incisions to function as adjustment actuators in the manner of draw strings for later adjustment of the adjustment spacings during the acute healing phase. The suture ends may be grasped and pulled to pull the sling intermediate ends closer together to decrease the adjustment spacing and thereby decrease the sling length and increase tension applied by the center support portion to the urethra or anus.

In a variation of this embodiment, the tensioning sutures are passed through suture or tissue anchors that engage subcutaneous muscle, the rectus fascia or the transobturator membrane and extend through the skin incisions employed to form the tissue pathway that the sling extends through. Alternatively, the tensioning sutures are passed through suture or tissue anchors that engage subcutaneous muscle, the rectus fascia or the transobturator membrane and extend through other skin incisions to be grasped and pulled on to adjust tension. For convenience, such subcutaneous muscle, the rectus fascia or the transobturator membrane or other membranes and fascia are collectively referred to as tissue layers herein.

In another embodiment, the external adjustment actuator comprises a signal transmitter that is employed to generate a sling adjustment command that passes transcutaneously (through the intact skin), and the adjustment mechanism comprises a receiver for receiving the transmitted commands and increases or decreases the adjustment spacing. In yet further embodiments, the external adjustment actuator is a magnetic field generator or permanent magnet that is employed to generate a magnetic field representing a sling adjustment command that passes transcutaneously through the skin, and the adjustment mechanism comprises a magnetic field responsive element that responds by increasing or decreasing the adjustment spacing. In still further embodiments, the sling tension adjustment mechanism comprises a temperature responsive element responsive to heat or cold applied transcutaneously by an external thermal heater or cooler to heat or cool the adjustment mechanism to thereby increase or decrease the adjustment spacing. In yet further embodiments, the sling tension adjustment mechanism comprises light responsive elements responsive to certain wavelengths of light that can be generated by an external adjustment actuator and transmitted transcutaneously to the sling tension adjustment mechanism to thereby increase or decrease the adjustment spacing.

In still another embodiment, the external adjustment actuator is inserted percutaneously (penetrating the skin) to engage and operate the sling tension adjustment mechanism to increase or decrease the adjustment spacing. Various sling tension adjustment mechanisms are provided that can be rotated by the external adjustment actuator in one direction to draw the sling intermediate ends together to increase sling tension and that can be rotated in the other direction to allow the sling intermediate ends to separate apart to decrease sling tension.

In yet another embodiment, the external adjustment actuator is a syringe or the like that is inserted percutaneously to engage a port of a fluid retaining chamber of the sling tension adjustment mechanism, whereby the adjustment spacing is adjusted by injecting or withdrawing fluid from the fluid chamber to increase or decrease the adjustment spacing. In certain variations, the sling tension adjustment mechanism comprises a fluid reservoir to be implanted just below the skin, a fluid chamber disposed in the adjustment spacing and coupled to the intermediate ends, and a tube extending between the fluid reservoir and the fluid chamber in each sling end portion. The fluid reservoir has a fluid delivery/withdrawal port that may be percutaneously accessed to introduce fluid into the fluid reservoir or to withdraw fluid from the fluid reservoir following implantation of the sling to thereby adjust the amount of fluid in the fluid chamber and adjust the length of the adjustable spacing.

In certain embodiments, the fluid chamber comprises a single action hydraulic cylinder disposed in the adjustment spacing coupled to one sling intermediate end, the cylinder containing a fluid operated piston within an elongated chamber, the cylinder coupled to a sling adjustment rod that is in turn coupled to the other sling intermediate end. The fluid volume introduced into the fluid chamber determines the piston location in the cylinder and the resulting length of the adjustment spacing. In a variation, a dual action hydraulic cylinder having a pair of opposed pistons in the fluid chamber are each coupled to rods that are in turn coupled to sling intermediate ends governs the adjustment spacing.

In these embodiments, the fluid chambers are preferably empty of fluid when the sterile sling is supplied in the sterile package from the manufacturer. Implantation of the sling through body pathways may be simpler and easier with the fluid chambers empty. The fluid, e.g., a sterile saline or other biocompatible hydraulic fluid, may be introduced through the fluid delivery port(s) while the port(s) are still accessible. The amount of fluid necessary to effect blockage of the urethral tract may be checked by draining and filling the patient's bladder through the urethral tract, determining efficacy, and adding or withdrawing fluid to adjust the applied urethral pressures in the pressurized and ambient pressure fluid distribution states. Similar procedures may be employed to effect constriction of the anal canal.

In further embodiments the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin. The adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing.

Optionally, sling end tissue anchors may be provided on sling ends to engage tissues, e.g., the rectus fascia or the obturator membrane to fix the sling ends and aid in tension adjustment of the sling end portions.

Optionally, a sling adjustment mechanism may be incorporated into the sling central support portion to enable the separate tensioning of the sling central support portion.

Various embodiments of the sling tension adjustment mechanism can include a plunger device adapted for traversal within an interior of the housing, and an inflatable bladder provided within the housing to selectively control traversal of the plunger. The plunger and tension adjustment mechanism are operatively connected to the sling such that adjustment of fluid volume within the inflatable bladder controls traversal of the plunger and, in turn, the length of the sling.

In another embodiment, the adjustment mechanism can include a bobbin device or spool within the housing and one or more retention devices to selectively restrict unwinding of a suture from the bobbin device. The suture is operatively connected to the sling such that adjustment of the retention device selectively controls the length of the suture extending from the spool or bobbin device and, in turn, the length of the sling.

This summary of the invention has been presented here simply to point out some of the ways that the invention overcomes difficulties presented in the prior art and to distinguish the invention from the prior art and is not intended to operate in any manner as a limitation on the interpretation of claims that are presented initially in the patent application and that are ultimately granted.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other advantages and features of the present invention will be more readily understood from the following detailed description of the preferred embodiments thereof, when considered in conjunction with the drawings, in which like reference numerals indicate identical structures throughout the several views, and wherein:

FIG. 1 is a schematic view of an exemplary sling assembly enclosing a sling adapted to be modified in accordance with the invention to function as an adjustable tension urethral or fecal sling;

FIG. 2 is a schematic illustration of the sling of FIG. 1 adapted to be modified in accordance with the invention to provide an adjustable tension function;

FIG. 3 is a schematic illustration of a urethral sling of FIG. 2 implanted in a female patient's body in relation to the urethra or bladder neck;

FIG. 4 is a schematic illustration of a fecal sling of FIG. 2 implanted in a female patient's body in relation to the anus and rectum;

FIG. 5 is a schematic illustration of the relation of the sling central support portion and sling end portions to the urethra or anus;

FIG. 6 is a schematic illustration of a generic embodiment of an adjustable tension sling of the present invention having sling tension adjustment mechanisms formed in gaps or spaces in the sling mesh forming the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing;

FIG. 7 is a schematic illustration of the generic embodiment of FIG. 6 having optional tissue anchors extending from the sling ends to aid in the operation of the sling tension adjustment mechanisms;

FIGS. 8 and 9 are schematic illustrations of an embodiment of an adjustable tension sling, wherein sliding locks that engage intermediate ends or loops of the sling mesh are incorporated into the sling end portions to increase and/or decrease the sling tension;

FIG. 10 is a schematic illustration of a further embodiment of an adjustable tension sling, wherein sling tension adjustment sutures bridge adjustment spacings in the sling end portions and extend through the skin to increase and/or decrease the sling tension;

FIG. 11A is a schematic illustration of a variation of the adjustable tension sling of FIG. 10, wherein the sling tension adjustment sutures extend through or around tissue anchors and extend through the skin to be available to increase and/or decrease the sling tension;

FIG. 11B is a schematic illustration of a further variation of the adjustable tension sling of FIG. 10, wherein the sling ends incorporate tissue anchors passed through and engaging tissue layers and the tension adjustment sutures extend through or around further tissue anchors and extend through the skin to be available to increase and/or decrease the sling tension;

FIGS. 12 and 13 are schematic illustrations of further preferred embodiments of an adjustable tension sling having sling tension adjustment mechanisms bridging adjustment spacings in the sling end portions adapted to be adjusted by commands transcutaneously transmitted from an external adjustment actuator to increase and/or decrease the tension applied locally to the urethra;

FIGS. 14-17 are schematic illustrations of further preferred embodiments of an adjustable tension sling having sling tension adjustment mechanisms bridging adjustment spacings in the sling end portions comprising serpentine roller adjustment mechanisms that adjusts the length of an adjustment spacing in response to an externally applied command;

FIG. 18 is a schematic illustration of a further preferred embodiment of an adjustable tension sling, wherein the adjustment mechanism is adjusted by an external adjustment actuator comprising an external adjustment actuator having an engaging end at the end of a shaft adapted to be percutaneously advanced into engagement with the adjustment mechanism to adjust the length of an adjustment spacing between intermediate sling ends in the sling end portions;

FIG. 19 is a schematic illustration of one embodiment of the sling tension adjustment mechanisms of FIG. 18 employing a rotatable bobbin, a fixed catch and detents around the bobbin circumference;

FIGS. 20-22 are schematic illustrations of the adjustment mechanism of FIG. 19 that adjusts the length of an adjustment spacing in response to an externally applied external adjustment actuator;

FIG. 23 is a schematic view in section of a variation on the embodiment of FIG. 19, wherein the adjustment mechanism housing supports a rotatable bobbin surrounded by a fixed detent ring providing an increased range of adjustments;

FIGS. 24-26 are schematic plan illustrations of a further embodiment of the adjustment mechanism of FIG. 18, wherein a dual cam assembly having a first cam operates to decrease the adjustable spacings from the neutral length illustrated in FIG. 24 to the contracted length of FIGS. 25A-25D and a second cam operates to increase the adjustable spacings to the extended length of FIGS. 26A-26D;

FIG. 27 is a schematic illustration of a further preferred embodiment of the adjustable tension sling, wherein the adjustment mechanism is adjusted by an external fluid delivery/withdrawal syringe adapted to be percutaneously advanced into engagement with a fluid port of the adjustment mechanism to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIGS. 28-31 are schematic plan side or top views illustrating one, single action, hydraulic cylinder, adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIGS. 32-36 are schematic perspective, side or top views in partial section illustrating a further single action, hydraulic cylinder, adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIGS. 37-40 are schematic perspective or top views illustrating a still further single action, hydraulic adjustment mechanism of FIG. 27 having a fluid chamber adapted to be filled or be emptied of fluid using the syringe of FIG. 27 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIG. 41 is a schematic illustration of a further preferred embodiment of the adjustable tension sling, wherein the adjustment mechanism is adjusted by an external fluid delivery/withdrawal syringe adapted to be percutaneously advanced into engagement with a fluid port of a subcutaneously implantable fluid reservoir coupled to the adjustment mechanism to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIGS. 42-44 are schematic perspective views in partial section illustrating a single action, hydraulic cylinder, adjustment mechanisms of FIG. 41 having fluid chambers adapted to be filled or be emptied of fluid using the syringe of FIG. 41 to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIG. 45 is a perspective view in partial section of a further single action, hydraulic cylinder, adjustment mechanism adapted to be employed as depicted in FIG. 41 having fluid chamber portions adapted to be filled or be emptied of fluid using a syringe to add or withdraw fluid from subcutaneously implanted fluid reservoirs coupled to the fluid chamber portions to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIG. 46 is a perspective view in partial section of a dual action, hydraulic cylinder, adjustment mechanism adapted to be employed as depicted in FIG. 41 having fluid chamber portions adapted to be filled or be emptied of fluid using a syringe to add or withdraw fluid from subcutaneously implanted fluid reservoirs coupled to the fluid chamber portions to adjust the length of the adjustment spacing between intermediate sling ends in the sling end portions;

FIGS. 47 and 48 are schematic plan views in partial section illustrating one form of locking mechanism incorporated into the single action hydraulic cylinder adjustment mechanism of FIGS. 28-31;

FIGS. 49 and 50 are schematic plan views in partial section illustrating another form of locking mechanism incorporated into the single action hydraulic cylinder adjustment mechanism of FIGS. 28-31;

FIG. 51 is a schematic Illustration of a miniaturized, single action, hydraulic cylinder, adjustment mechanism incorporating the locking mechanism illustrated in FIGS. 47 and 48;

FIG. 52 is a side plan view of the miniaturized, single action, hydraulic cylinder, adjustment mechanism of FIG. 51;

FIG. 53 is a top plan view in partial section of the miniaturized, single action, hydraulic cylinder, adjustment mechanism of FIG. 51;

FIG. 54 is a schematic Illustration of a miniaturized, mechanical gear, adjustment mechanism that is adjusted by a gear drive extended temporarily through the patient's skin;

FIG. 55 is a schematic expanded view in partial section illustrating the gear drive components within the adjustment mechanism of FIG. 54;

FIG. 56 is a schematic Illustration of a further miniaturized, mechanical gear, adjustment mechanism that is adjusted by a gear drive external adjustment actuator extended percutaneously through the patient's skin to engage the gear drive and adjust sling tension;

FIG. 57 is a schematic Illustration of a still further miniaturized, mechanical gear, adjustment mechanism that is adjusted by a rack and pinion gear drive extended temporarily through the patient's skin; and

FIGS. 58A-58D are schematic views in partial section illustrating adjustment of sling tension through use of the rack and pinion gear drive extended temporarily through the patient's skin to adjust the miniaturized, mechanical gear, adjustment mechanism of FIG. 57.

FIG. 59A is a perspective view of a sling tension adjustment mechanism or assembly having a plunger device.

FIG. 59B is a schematic sectional view of the sling tension adjustment mechanism or assembly of FIG. 59A.

FIGS. 59C-59D are schematic sectional views of a sling tension adjustment mechanism or assembly having a plunger device and an inflatable bladder.

FIG. 59E is a schematic sectional view of a sling tension adjustment mechanism or assembly having a plunger device with sealing features.

FIG. 60A is a perspective view of a sling tension adjustment mechanism or assembly operatively connected to a sling.

FIG. 60B is a top view of a sling tension adjustment mechanism or assembly operatively connected to a sling, with adjustment features.

FIG. 60C is a top view of a sling tension adjustment mechanism or assembly operatively connected to a sling, with adjustment tool indexing features.

FIG. 60D is a top view of a sling tension adjustment mechanism or assembly with adjustment tool indexing features and a corresponding adjustment tool.

FIGS. 60E-60F are schematic sectional views of a sling tension adjustment mechanism having a bobbin device, suture wrapped around the bobbin device and a set crew feature for restricting the bobbin device and/or suture unwinding.

FIGS. 60G-60J are schematic sectional views of a sling tension adjustment mechanism having a bobbin device, and member and detent features for restricting the bobbin device and/or suture unwinding.

FIGS. 60K-60L are schematic sectional views of a sling tension adjustment mechanism having a bobbin device, and a locking feature for restricting the bobbin device and/or suture unwinding.

FIGS. 60M-60R are schematic sectional views of a sling tension adjustment mechanism having a bobbin device, suture wrapped around the bobbin device and pinching features for restricting the bobbin device and/or suture unwinding.

The drawing figures are not necessarily to scale.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

The various embodiments of the present invention are implemented in slings suitable for and methods of implanting such slings in the treatment of male and female urinary and fecal incontinence and to effect pelvic floor, perineal floor, and pelvic proplapse repairs employing a variety of surgical approaches. For example, female pelvic floor repair slings may be implanted by techniques that involve transvaginal, transobturator, suprapubic, pre-pubic, or transperineal exposures or pathways, and male urinary incontinence slings may be implanted by techniques that involve transobturator, suprapubic, or transperineal pathways. Any of the disclosed embodiments can be used as fecal incontinence slings which may be implanted by techniques that involve transvaginal, transobturator, suprapubic or via perineal floor pathways. In fecal incontinence applications, the disclosed embodiments can be used to correct the anorectal angle in the rectum to re-establish continence in patients. The above methods can, but are not necessarily limited to, utilize helical needles of the type described in U.S. Pat. No. 6,911,003 or C-shaped needles or elongate needles of the type used to perform suprapubic procedures.

Referring to FIG. 1, an exemplary embodiment of an elongated sling assembly 10 is depicted in which the embodiments of the present invention may be advantageously implemented. The elongated sling assembly 10 contains a sling 20 that may be implanted in any of the above-described manners and pathways pathways through which at least end portions of the elongated sling assembly 10 is drawn to dispose a central support portion 40 of sling 20 in operative relation to the urethral or bladder neck or around the anal sphincter or elsewhere in the pelvic region. The sling assembly 10 comprises the sling 20 coupled to sling end connectors 12 and 14 and encased in protective sheaths 22 and 24.

The depicted exemplary sling assembly 10 thus extends between sling end connectors 12 and 14 that engage with the free ends of right hand and left hand sling implantation tools of the types described above, for example. The sling end connectors 12 and 14 are shaped to dilate the right and left passages or pathways through body tissue formed by the curved needles of the right and left hand implantation tools in the above-described trans-vaginal or transobturator procedures, for example.

In this example, the sling 20 is enclosed within protective sheaths 22 and 24 extending from the sling end connectors, 12 and 14, respectively, to respective free and open sheath ends 26 and 28. Preferably, the protective sheaths 22 and 24 are constructed of a flexible thin transparent plastic film that enables visual examination of the sling 20 and is sufficiently lubricious that it passes easily through the tissue pathways of the patient formed using the right hand and left hand sling implantation tools of the types described above or otherwise created. The sheaths 22 and 24 can include sheath indicia or tear scores, perforations or holes for assisting the surgeon in properly orienting sling 20 relative to the urethra. Embodiments of the present invention are contemplated that involve modifying the sheaths 22 and 24.

The sling 20 that is left in place chronically (following implantation and removal of sheaths 22 and 24 and end connectors 12 and 14) comprises an elongated, rectangular (in this depicted embodiment) braided or preferably knitted, mesh strip or simply mesh 30 as shown in FIG. 2. The sling 20 and mesh 30 are subdivided into a central support portion 40 that is adapted to be placed through a pathway extending between the urethra or bladder neck and the vaginal wall. Proximal end portions 42 and 44 of sling 20 extend from the central support portion 40 to the mesh ends 32 and 34. In FIGS. 1-5, the mesh 30 extends between mesh ends 32 and 34 and may be continuous throughout the length of the sling 20 between mesh ends 32 and 34. However, it will be understood that the central portion 40 of sling 20 may be formed of other materials such that the central portion 40 is physically attached to the end portions 42 and 44. In certain embodiments, the central portion 40 may be formed of any tissue-compatible synthetic material or any natural biocompatible material, including, but not limited to, treated autologous, allograft, or xenograft tissues, porcine dermis, a tissue engineered matrix, or a combination thereof.

The sling 20 of sling assembly 10 is therefore similar to those the disclosed in the above-referenced '450 and '003 patents but is modified herein to incorporate one or more of the aspects of the present invention. It will be understood that the mesh 30 may be dimensioned shaped in a variety of ways known in the art for implantation in the treatment of male and female urinary and fecal incontinence and to effect pelvic floor, perineal floor, and pelvic proplapse repairs employing a variety of surgical approaches. For example, the sling 20 may comprise more than two end portions 42 and 44 coupled to connectors and extending at a variety of angles from a particularly shaped center portion 40.

In the implantation procedures described in the above-referenced '214, '450, and '524 patents and U.S. Patent Application Publication Nos. 2005/0043580 and 2005/0065395, the sling connector ends 12 and 14 are fitted to the implantation tools and the proximal end portions 42 and 44 are drawn through the body passageway or pathway. The central support portion 40 is adapted to drawn against tissue to support the urethra or bladder neck or the anal sphincter or elsewhere in the pelvic region after the proximal end portions 42 and 44 are drawn through body pathways. The sling connector ends 12 and 14 are drawn out of the skin incision and detached from the implantation tool needle ends. The mesh 30 and sheaths 22 and 24 are severed just proximate to the connector ends 12 and 14, respectively. The remaining portions of the protective sheaths 22 and 24 are withdrawn over the mesh 30 and through the skin incisions. The sling 20 then remains in place, and tension adjustments are made to provide sufficient urethral or anal resistance to leakage. The incisions are closed upon completion of the tests, and tissue ingrowth into the pores of the mesh 30 takes place in a matter of weeks.

Before describing the embodiments of the invention, attention is directed to a step illustrated in FIG. 3 of one such sling implantation procedure that results in the sling 20 extending through a tissue pathway created in a female (for example) patient 50 extending around the urethra 58. In preceding steps, the tissue pathway was formed by passing needles through a vaginal skin incision 62 just adjacent to the vagina 60 through soft tissue between urethra 58 and vagina 60 and along each side of urethra 58 through layers of fat, muscle, and fascia and between pubic bone 54 and bladder 56 to first and second skin incisions through skin 52. Any of the known tissue pathways may be formed in this generally described manner. In a related embodiment, a sling is implanted via a single incision (vaginal incision 62) with the sling being pushed up into the transobturator or retro pubic space. The end connectors 12 and 14 of the sling assembly 10 were attached to the same or other needles to draw the sling assembly 10 through the tissue pathway to dispose the end connectors outside the patient's skin 52. As shown in FIG. 3, the connectors 12 and 14 and sheaths 22 and 24 were removed after being drawn out of the skin incisions, leaving the sling 20 in place. In a related embodiment, connectors 12 and 14 are eliminated.

Referring to FIG. 4, a schematic illustration of an incontinence sling implanted in a female (for example) patient's body for treating fecal incontinence is depicted. In this illustration, the sling central portion 40 extends underneath the anus or anal sphincter 67 or inferior portion of the rectum 65 (hereafter collectively referred to as the anus 67 for convenience) to correct the anorectal angle in the patient. Various surgical approaches can be used to implant sling 20 to correct fecal incontinence including suprapubic, transobturator, retropubic, prepubic, transperineal and transvaginal (including a single incision approach transvaginally or transperineally).

At this point, the tension T that sling 20 applies against the urethra 58 or anus 67 is adjusted as schematically illustrated in FIG. 5. Since the procedure may be performed using a local anesthesia, the patient 50 is able to provide feedback to the surgeon during adjustment of sling tension. In the procedure illustrated in FIG. 3, typically, the bladder 56 is filled with saline using a catheter, and the patient is requested to cough. The surgeon is able to determine whether leakage occurs and may adjust the tension on the sling 20 by pulling on the exposed sling ends 32 and 34 to increase tension of the center support portion 40 against the urethra 58 or by pulling on center support portion through the vaginal incision to decrease the tension of the center support portion 40 against the urethra 58. The exposed end sections of the end portions 42 and 44 are trimmed away, and the abdominal incisions and the vaginal incision (as well as the labia fold incisions for the transobturator approach) are closed. In the various embodiments of the present invention, such slings as sling 20 are improved to enhance post-operative sling adjustment of the tension T applied to the urethra 58 or the anus 67 to enhance efficacy and patient comfort.

While not essential to the practice of the present invention, it may be desirable to provide mechanisms incorporated into or that act on the sling central support portion 40 to facilitate the adjustment of the tension T applied to the urethra 58 or the anus 67. For example, a sling central portion adjustment mechanism may be provided to increase and/or decrease the tension applied locally to the urethra 58 or the anus 67. The sling central portion adjustment mechanism is associated directly or indirectly with the sling central support portion 40 and is distinct from the sling tension adjustment mechanisms incorporated in the sling end portion or portions.

For example, as shown in FIG. 10, the sling central portion tension adjustment may simply comprise a suture 108 extending around the sling central portion and passing through the skin incision to provide post-operative tension adjustment of the sling central portion 40 by pulling on sling ends 106. Adjustments may be made until the suture is withdrawn through the skin 52 or is absorbed by the body.

Longer-term post-operative adjustment of the sling central portion tension may be accomplished with sling central portion adjustment mechanisms that remain in place. In one approach, the mechanism may be accessed for tension adjustment employing an external adjustment actuator that is percutaneously advanced through the skin 52 to engage the sling central portion adjustment mechanism. For example, one such approach involves injecting or withdrawing fluid from a fluid chamber of a pillow of the sling central portion adjustment mechanism applying pressure to the urethra 58 or the anus 67.

In certain more complex embodiments of the second category, sling tension adjustment mechanisms are formed in gaps in the sling mesh forming the sling end portions such that the sling tension adjustment mechanisms are interposed between and attached to sling intermediate ends that are spaced apart by an adjustment spacing. Various mechanisms and techniques are employed to adjust the sling tension adjustment mechanisms to decrease or increase the adjustment spacing between the sling intermediate ends to thereby shorten or lengthen, respectively, the overall length of the sling end portions and to thereby increase or decrease, respectively, the tension applied by the central support portion to the urethra. The sling tension adjustment mechanisms are disposed along the sling end portions so as to be disposed at tissue pathway locations that are proximate the patient's skin to enable access to or application of the external adjustment actuator against the skin or through the skin and underlying tissues to operate the sling tension adjustment mechanisms.

Turning to FIGS. 6 and 7, in accordance with embodiments of the present invention, a sling tension adjustment mechanism is incorporated into or on a section of one or preferably both of the sling end portions 42 and 44 proximal to but spaced from the central support portion 40 that can be adjusted at least in the acute post-operative healing phase. A first sling end portion tension adjustment mechanism 102 is schematically depicted extending between and coupled to sling intermediate ends 36 and 38 of sling end portion 42. The gap or adjustment spacing 162 between sling intermediate ends 36 and 38 is shortened to increase tension or lengthened to decrease tension in sling end portion 42. Similarly, a second sling end portion tension adjustment mechanism 104 is schematically depicted extending between and coupled to sling intermediate ends 46 and 48 of sling end portion 44. The gap or adjustment spacing 164 between sling intermediate ends 46 and 48 is shortened to increase tension or lengthened to decrease tension in sling end portion 44. The spacing of each sling tension adjustment mechanism 102 and 104 from the central support portion 40 is selected in relation to the anatomy for either male or female fecal or urinary incontinence slings and the implantation route or technique to facilitate access or engagement with an externally applied adjustment actuator or an actuator element extending percutaneously from a skin incision. The adjustment mechanisms are generally adjusted to adjust the length and/or tension of the end portions 42 and 44 to thereby tension the center support portion 40 and draw it closer to the urethra 58 or anus 67 to relax tension of the center support portion 40 to release pressure on the urethra 58 or anus 67.

As shown in FIG. 7, it may be desirable to stabilize the sling ends 32 and 34 in tissue by optionally providing sling tissue anchors 92 and 94 extending from the sling ends 32 and 34. The anchors 92 may take any of the forms disclosed in the above-referenced U.S. Patent Application Publication No. 2005/0004576, for example. Generally speaking such tissue anchors 92 and 94 can be readily drawn through tissue in the direction away from the sling ends 32 and 34, respectively, but resist retraction back through the tissue. Advantageously, the sling tissue anchors 92 and 94 may be extended through and bear against the rectus fascia or the transobturator to stabilize the sling ends 32 and 34 to set sling tension and to resist being drawn toward the sling tension adjustment mechanisms 102 and 104 when tension is increased.

In certain particular embodiments of the invention depicted in FIGS. 8 and 9, the end portion tension adjustment mechanisms comprise sliding locks 132 and 134 (FIG. 8) or 142 and 144 (FIG. 9) that engage the end portions 42 and 44 of the sling mesh 30. In one variation shown in FIG. 16, sections of the sling mesh 30 are looped and passed through channels of sliding locks 132 and 134. In the other variation shown in FIG. 9, the sling intermediate ends are drawn through channels of the sliding locks 142 and 144. It will be understood that the depicted slings 20 are disposed in the patient's body the manner depicted in FIG. 3 or FIG. 4. The loops 136, 138 or free ends 146, 148 function as actuator elements that can be grasped through the skin incisions 82 and 84 (or through a vaginal incision if a single incision approach is chosen) and pulled upon with respect to the sliding locks 132, 134 or 142, 144 to shorten the lengths of the end portions 42, 44 and increase tension on the urethra 58.

Sliding locks 132, 134 and 142, 144 operate similar to zip-tie locks. It will be understood that the depicted loops 136, 138 and the free ends 146, 148 can comprise sutures or zip-lock tapes fastened to intermediate ends of the sling mesh 30 so that the sutures or zip-lock tapes are drawn through channels of the sliding locks 132,134 and 142,144.

A further specific embodiment of the present invention is depicted in FIG. 10, wherein the end portion 42 is severed at intermediate ends 36 and 38 to form a gap or adjustment spacing 162, and the end portion 44 is severed at intermediate ends 46 and 48 to form a gap or adjustment spacing 164. Sutures 156 and 158 are threaded back and forth through mesh pores adjacent the intermediate ends 36, 38 and 46, 48, respectively, and across the respective adjustment spacings 162 and 164, to function as draw strings for later adjustment of the adjustment spacings 162 and 164 during the acute healing phase. The suture 156 and adjustment spacing 162 comprise sling end portion tension adjustment mechanism 152 of end portion 42, and the suture 158 and adjustment spacing 164 comprise sling end portion tension adjustment mechanism 154 of end portion 44.

In this embodiment, the suture ends 166 and 168 of respective sutures 156 and 158 extending from the skin incisions 82 and 84 during implantation of the sling 20 function as the adjustment actuators. The suture ends 166 and 168 may be grasped and pulled to shorten the adjustment spacings 162 and 164 to thereby shorten the sling end portions 42 and 44 and thereby decrease the sling length and increase tension applied by the center support portion 40 to the urethra 58 (or anus).

A further adjustment suture 108 (optionally formed of biodegradable material) is optionally placed around the sling mesh 30 and extended through the vaginal skin incision 62 to enable manual tension adjustment. The suture ends 106 may be grasped and pulled to function as an actuator element and pull the sling mesh away from the urethra 58 to release tension applied by the center support portion 40 to the urethra 58 (or anus).

In the absence of adjustment suture 108, the sling central support portion 40 may be accessed by reopening the vaginal incision 62 to pull on the sling 20 to draw the sutures 156 and 158 back through the mesh pores, thereby increasing the sling length and decreasing tension applied by the center support portion 40 to the urethra 58 (or anus).

Optionally, a biodegradable sheath may be placed over the adjustment mechanisms 152 and 154 and at least a portion of the sling mesh to inhibit tissue ingrowth into the mesh pores and adjustment spacings 162 and 164 and thereby ease adjustment of the sling 20 until the sheath is absorbed and tissue ingrowth encapsulates and immobilizes sling mesh 30.

The suture ends 166, 168, and 106 may be severed at the respective incisions 82, 84, and 62 following final adjustment.

Certain sling implantation procedures for urethral and fecal slings involve employing implantation instruments having needles that are advanced from a first skin incision to a second skin incision to form first and second or right and left (non-suprapubic) tissue pathways around the urethra 58 or the anus 67. The instruments or other instruments are then employed to push or pull the sling end portions 42 and 44 through the first and second pathways to dispose the sling ends near or through the skin incisions 82 and 84 as shown in FIGS. 3 and 4. The above-described embodiments contemplate implantation in such tissue pathways.

Other sling implantation procedures for urethral and fecal slings have sling ends configured to engage sling implantation tool needle ends to be pushed from a single incision adjacent the urethra 58 (or the anus 67) through first and second tissue pathways to dispose the sling end portions extending away from the urethra 58 (or anus 67). The skin incisions 82 and 84 are not necessarily made, and the sling ends are disposed at subcutaneous locations.

In a variation of this embodiment of the invention depicted in FIG. 11A, the sutures 156 and 158 are drawn through tissue anchors 96 and 98 that are passed through and bear against subcutaneous tissue layers 72 and 74, respectively. Generally speaking, the tissue anchors 96 and 98 have channels or bores that one or both of the sutures 116 and 118 are passed though that grip the sutures with sufficient force to maintain sling tension. The suture retaining force may be overcome by manipulation of the suture and tissue anchor to increase or decrease sling tension during post-operative recuperation. The suture ends extending through the skin incisions 82 and 84 are placed under the skin 52, and the incisions are closed. During chronic implantation, adjustments of sling tension may take place by reopening the skin incisions 82 and 84 to access the suture ends and the tissue anchors 96 and 98.

In this embodiment, the suture 156 passes through a slidable bore of the tissue anchor 96 and through the same skin incision 82 that the tissue pathway is created for the sling 20. Similarly, the suture 158 is depicted extending through a slidable bore of the tissue anchor 98 and through the same skin incision 84 that the tissue pathway is created for the sling 20. For example, the tissue pathway may extend through the right and left transobturator membranes (tissue layers 72 and 74) that the tissue anchors 96 and 98 are passed through and bear against.

In a further variation of this embodiment of the invention depicted in FIG. 11B, tissue anchors 632 and 634 are coupled to the sling ends 32 and 34, respectively, and the sutures 156 and 158 are passed through the tissue anchors 96 and 98. In the implantation procedure, the tissue anchor 632 and the sling end portion 42 are pushed from a single skin incision below the urethra 58 or anus 67 through a first tissue pathway such that the tissue anchor 632 is passed through and bears against tissue layer 72. Similarly, the tissue anchor 634 and the sling end portion 43 are pushed from the skin incision below the urethra 58 or anus 67 through a second tissue pathway such that the tissue anchor 634 is passed through and bears against tissue layer 74.

The suture 156 and tissue anchor 96 are pushed through a further tissue pathway such that the tissue anchor 96 is passed through and bears against a separate tissue layer 76 and then through a skin incision 86. Similarly, the suture 158 and tissue anchor 98 are pushed through a further tissue pathway such that the tissue anchor 96 is passed through and bears against a separate tissue layer 76 and then through a skin incision 88. Alternatively, the sutures 156 and 158 can first be passed by themselves through the skin incisions 86 and 88, respectively, and the tissue anchors 96 and 98 can be applied over the sutures 156 and 158 to bear against the tissue layers 76 and 78, respectively. In a related embodiment, the various sling embodiments can be used without tissue anchors.

Tension can be applied by pulling on the suture ends of sutures 156 and 158, respectively while applying pressure against the subcutaneous tissue anchors 96 and 98, thereby decreasing the spacings 162 and 164. Tension on sutures 156 and 158 can be release to lengthen spacings 162 and 164 by exposing and manipulating the tissue anchors 96 and 98.

It will be understood that the tissue layers 72, 74, 76, and 78 may comprise a muscle layer, fascia or transobturator membrane. Tissue layers 72 and 76 may be the same or a different tissue layer, and tissue layers 74 and 78 may be the same or a different tissue layer. The particular locations of skin incisions 86 and 88 and the respective tissue anchors 96 and 98 may include obturator, abdominal, pelvic, perineal and rectal regions.

The tissue anchors 632, 634, 96, and 98 may take any of the forms disclosed in the above-referenced '002 patent and in U.S. Patent Application Publication Nos. 2005/0004576 and 2006/0089525.

A wide variety of other specific embodiments of the invention employing adjustment mechanisms bridging a gap between the sling intermediate ends 36, 38 and 46, 48 to adjust spacings 162 and 164 are contemplated. In the following embodiments, the adjustment actuator acts upon the sling end portion adjustment mechanisms 102 and 104 by percutaneous direct access to an adjustment tool or transcutaneous transmission of adjustment commands to an adjustment control of the adjustment mechanism. In these embodiments, both shortening and lengthening of the length of the adjustment spacings 162 and 164 for increasing and decreasing sling tension are contemplated by these embodiments.

Referring to FIG. 12, adjustment mechanism 202 is disposed across the adjustment spacing 162 and affixed to sling intermediate ends 36 and 38, and adjustment mechanism 204 is disposed across the adjustment spacing 164 and affixed to sling intermediate ends 46 and 48. An external adjustment actuator 200 is depicted brought into proximity to or applied against the skin 52 for generating an adjustment command 210 that is communicated transcutaneously through the skin 52 and underlying fat, tissue and fascia to adjustment mechanism 204. It will be understood that the external adjustment actuator 200 may also be brought into proximity to the skin 52 for generating a similar adjustment command communicated transcutaneously through the skin 52 and underlying fat, tissue and fascia to adjustment mechanism 202. The adjustment mechanisms 202 and 204 comprise electromechanical systems or elements or materials that respond to the transmitted command 210 to effect the adjustment in length of the adjustable spacings 162 and 164. In a related embodiment, mechanisms 202 and 204 are shape memory alloy (e.g. nitinol) elements that contract in size and expand in size depending on the stimulus.

In one variation of this embodiment depicted in FIG. 13, the external adjustment actuator 200 is an RF signal generator that generates an RF signal 210 through antenna 206 applied to the patient's skin as command 210. The adjustment mechanisms 202 and 204 each incorporate an RF antenna 216 that receives the RF signal and apply the received signal to internal electromechanical drive mechanism 218 for extending or contracting the length of the adjustment mechanisms 202 and 204.

Alternatively, the RF signal 210 is a power signal that is received by antenna 216 to generate a current that is applied to resistive heating elements or heat responsive elements forming the electromechanical drive mechanism 218 of each of adjustment mechanisms 202 and 204. For example, the electromechanical drive mechanism 218 of the adjustment mechanisms 202 and 204 may comprise chambers holding a heat responsive fluid that expands as heat is applied, and the expanded fluid drives pistons in the chambers to increase the overall length of the adjustment mechanisms 202 and 204. Or, the electromechanical drive mechanism 218 may comprise a heat responsive bi-metal strip that is heated by the received current and expands or contracts in length to expand or contract the length of the adjustment mechanisms 202 and 204.

Alternatively, the external adjustment actuator 200 generates a pulsed or steady magnetic field as the command 210. The adjustment mechanisms 202 and 204 incorporate magnetic responsive switches, e.g., reed switches or MAGFETs within the electromechanical drive mechanism 218 that switch states and operate the electromechanical drive mechanism 218 to extend or contract the length of the adjustment mechanisms 202 and 204.

Alternatively, the external adjustment actuator 200 is simply a heating or chilling pad that is applied to the skin to locally heat or cool the underlying tissue and the adjustment mechanisms 202 and 204 to expand or contract a heat responsive element or material that is incorporated into the adjustment mechanisms 202 and 204. The heating and/or cooling of the heat responsive element or material extends and/or or contracts the length of the adjustment mechanisms 202 and 204.

Alternatively, the sling tension adjustment mechanisms 202 and 204 comprise light responsive elements, and the external adjustment actuator 200 comprises a light source (laser or diode) that emits light pulses of a light frequency capable of penetrating the skin and underlying fat layers and fascia as the command 210 that the light responsive elements are capable of detecting. An electromechanical drive mechanism 218 responds to the output signals of the light detectors to adjust the length of the adjustment mechanisms 202 and 204.

FIGS. 14-17 are schematic illustrations of a serpentine roller that may be incorporated into the adjustment mechanisms 202 and 204 to adjust the length of the adjustment spacings 162 and 164. The intermediate ends 36, 38 and 46, 48 are attached to ends of a band 230 that extends through a channel 226 of the housing 220, the channel 226 including two chambers 222 and 224. The band 230 extends around roller 232 disposed in chamber 222 and roller 234 disposed in chamber 224. The lengths of the adjustment spacings 162, 164 depend on the location of the rollers 232 and 234 in the respective channels 222 and 224.

A maximum length of the adjustment spacings 162, 164 is obtained with the rollers 232 and 234 disposed substantially out of the respective channels 222 and 224 as shown in FIG. 16. A minimum length of the adjustment spacings 162, 164 is obtained with the rollers 232 and 234 disposed fully within the respective channels 222 and 224 as shown in FIG. 17. An intermediate or neutral length of the adjustment spacings 162, 164 is obtained with the roller 232 disposed fully within the respective channels 222 and the roller 234 disposed substantially out of the respective channel 224 as shown in FIG. 15. The sling 20 would be implanted with the rollers 232 and 234 disposed in the neutral position of FIG. 15, and later adjustments to the position of FIG. 16 or FIG. 17 would be made with an external adjuster applied to the patient's skin 52. It is contemplated that movement of the rollers 232 and 234 would be controlled by an electromechanical interface between the rollers 232 and 234 and any mechanism responsive to commands 210 generated by the external actuator 200 as described above.

In further embodiments illustrated schematically in FIG. 18, the external adjustment actuator 310 has an actuator-engaging end 312 at the end of a shaft 314. The tension adjustment mechanisms 302 and 304 are shaped with actuator end receptacles 306 and 308, respectively, that can be manually palpated through the skin 52. The actuator engaging end 312 and shaft 314 can be inserted percutaneously through skin incisions 64 and 66 to fit the actuator engaging end 312 into the actuator end receptacles 306 and 308. The external adjustment actuator 310 is depicted in engagement (at separate times) with both actuator end receptacles 306 and 308 in FIG. 18. Various rotatable mechanisms within the tension adjustment mechanisms 302 and 304 are contemplated that can be rotated by manual rotation of the external adjustment actuator 310 in one direction to shorten the sling end portions 42 and 44 together to increase sling tension and that can be rotated by manual rotation of the external adjustment actuator 310 in the other direction to lengthen the sling end portions 42 and 44 to separate apart to decrease sling tension. The actuator engaging end 312 is shaped to both penetrate tissue and to have mating surfaces for engaging the end receptacles 306 and 308 to enable rotation in both directions.

The tension adjustment mechanisms 302 and 304 depicted in FIGS. 19-22 each comprise a bobbin 316 mounted for rotation in a receptacle of a housing 320 fixed at one end to the sling intermediate end 36, 46, the bobbin 316 shaped with the actuator end receptacles 306, 308 extending axially into one side of the bobbin 316. A band or strand 330 extends from a fixed connection with the other sling intermediate end 38, 48 into a channel 322 in housing 320 and around a groove of the bobbin 316 to a fixed coupling with the bobbin 316. The bobbin 316 is formed with three detents 332, 334, 336 spaced apart around its circumference, and the free end of a catch 324 fixed at its other end to housing 320 engages one of the detents 332, 334, 336.

In this embodiment, the actuator end receptacles 306, 308 have a five sided socket shape, and the engaging end 312 of the shaft 314 of external adjustment actuator 310 is also shaped as a mating five-side wrench having a distal point and is shown poised to be inserted into the actuator end receptacle 306, 308 in FIG. 19. The neutral position of the bobbin 316 at the time that the sling 20 is implanted is depicted in FIG. 20. At a later date, the external adjustment actuator 310 can be used to engage and rotate the bobbin 316 to either increase or decrease the amount of the band or strand 330 taken up on the bobbin groove and to thereby shorten or extend, respectively, the adjustment spacing 162, 164, and tighten or loosen, respectively, the sling 20 and increase or decrease, respectively, tension applied by the sling central support portion 40 to the urethra 58 (or anus).

As shown in FIG. 21, a minimum length of the adjustment spacing 162, 164 is obtained by clockwise rotation of the bobbin 316 to move the catch end 324 out of detent 334 and along the outer edge of the bobbin 316 until the catch end engages detent 336. As shown in FIG. 22, a maximum length of the adjustment spacing 162, 164 is obtained by counter-clockwise rotation of the bobbin 316 to move the catch end 324 out of detent 334 and along the outer edge of the bobbin 316 until the catch end engages detent 332.

An alternative detent arrangement of the bobbin and housing is depicted in FIG. 23. In this variation, the housing 340 supports a rotatable bobbin 346 surrounded by a fixed detent ring 342. The actuator-engaging receptacle 348 is shaped to receive an actuator end shaped like a three-sided Keith needle. A first band or strand 350 extends from a fixed end about a portion of the circumference of the bobbin 346 and is coupled at its other end to the intermediate end 36, 46 of the sling 20 formed of mesh 30. A second band or strand 352 extends from a fixed end about a portion of the circumference of the bobbin 346 and is coupled at its other end to the intermediate end 38, 48 of the sling 20. The rotatable bobbin 346 and fixed detent ring 342 further comprise a plurality of flexible tabs or teeth that interlock like gear teeth.

Again, a neutral position of the bobbin 346 is established at the time that the sling 20 is implanted is depicted. At a later date, the Keith needle style external adjustment actuator 310 can be used to engage the receptacle 348 and rotate the bobbin 346 clockwise to decrease or counterclockwise to increase the amount of the bands or strands 350, 352 taken up on the bobbin grooves. The clockwise and counterclockwise bobbin rotations thereby extend or shorten, respectively, the adjustment spacing 162, 164, and loosen or tighten, respectively, the sling 20 and decrease or increase, respectively, tension applied by the sling central support portion 40 to the urethra 58.

An alternative dual cam adjustment mechanism 362, 364 is depicted in FIGS. 24, 25A-25D, and 26A-26D disposed in the adjustable spacings 162, 164. The tension adjustment mechanisms 362, 364 each comprise a dual cam assembly 370 comprising a first cam 372 coupled to first tether 374 and a first cam follower 376 and a second cam 382 coupled to a second tether 384 and second cam follower 386. The ends of the first and second tethers 374 and 384 are coupled to the sling intermediate ends 36, 46, and 38, 48 respectively. The first cam 372 rotated with respect to cam follower 376 operates to decrease the adjustable spacings 162, 164 from the neutral length of FIG. 24 to the contracted length of FIG. 25A as shown in FIGS. 25B-25D. The second cam 382 rotated with respect to cam follower 38 operates to increase the adjustable spacings 162, 164 from the neutral length of FIG. 24 to the contracted length of FIG. 26A as shown in FIGS. 26B-26D. The external adjustment actuator 310 (FIG. 18) is operated to engage either the first or the second cam 372 or 382 to increase or decrease sling tension, respectively. Any suitable socket and actuator configuration may be employed for effecting selective rotation of the cams.

In yet further embodiments of the second category depicted schematically in FIG. 27, the external adjustment actuator is a syringe 410 or the like that is inserted percutaneously through a skin incision to engage a port 406, 408 of a fluid retaining chamber of the sling tension adjustment mechanism 402, 404.

In the embodiment depicted in FIGS. 28-31, the port 406, 408 comprises a penetrable, resealable septum, and a needle stop may be included within the fluid chamber opposite the resealable septum to prevent needle perforation of the wall of the fluid retaining chamber within the outer housing 415. The port 406, 408 is coupled to sling intermediate end 36, 46, and a rod 420 is coupled at its free end to the sling intermediate end 38, 48. The port 406, 408 accesses a cylinder within housing 422 so that the fluid delivered through the septum of the port 406, 408 is also delivered into the cylinder. A piston coupled to the rod 420 (which may simply be an enlarged diameter end of rod 420) is also enclosed within the cylinder of housing 422. Rod 420 extends through a C-shaped opening 417 in the end of outer housing 415 that guides but does not inhibit movement of rod 420. The adjustment spacing 162, 164 is adjusted by injecting or withdrawing fluid from the fluid chamber to laterally extend or retract the piston mounted rod 420 to increase or decrease the adjustment spacing 162,164 as shown in FIGS. 29-31.

A variation on this embodiment is depicted in FIGS. 32-36, wherein a sling tension adjustment mechanism 432, 434 is substituted for the sling tension adjustment mechanism 402, 404 of FIGS. 27-31. In this variation, the port 436 is formed with a syringe needle interlock 443, and the syringe 410 has a special interlocking tip 442 that opens and enters the interlock 443 to deliver or withdraw fluid from or to the syringe chamber 416. The port 436 is coupled to a housing 446 enclosing a cylinder or fluid chamber 444 that the fluid is delivered into. The interlock 443 is spring loaded by spring 440 within the port chamber 445. A piston 448 is also enclosed within the housing 446 and coupled to a rod 450 extending from the housing end. The port 436 is coupled to sling intermediate end 36, 46, and the rod 450 is coupled at its free end to the sling intermediate end 38, 48.

The volume of fluid delivered into the fluid chamber 444 dictates the position of the cylinder 448 within the chamber 444 and the extension of the rod 450. The adjustment spacing 162, 164 is therefore adjusted by injecting or withdrawing fluid from the fluid chamber 444 to laterally extend or retract the piston 448 and rod 450 to increase or decrease the adjustment spacing 162, 164 as shown in FIGS. 35-36.

The sling tension adjustment mechanisms 402, 404 and 432, 434 depicted in FIGS. 27-36 comprise single action, hydraulic pistons, wherein the fixed housing is coupled to one sling intermediate end and the movable rod end is coupled to the other intermediate sling end. It will be understood that the sling tension adjustment mechanisms 402, 404 and 432, 434 depicted in FIGS. 27-36 may be modified to function as dual action, hydraulic pistons having axially aligned and opposed pistons coupled to respective rods, and the rod free ends of each mechanism coupled to the sling intermediate ends 36, 46 and 38, 48.

A still further variation on this embodiment of the second category illustrated in FIG. 27 is depicted in FIGS. 37-40, wherein a sling tension adjustment mechanism 462, 464 is substituted for the sling tension adjustment mechanism 402, 404 of FIGS. 27-31. In this dual action variation, the external adjustment actuator is the syringe 410 or the like that is inserted percutaneously through a skin incision to engage a port 406, 408 of a fluid chamber 470 of the sling tension adjustment mechanism 462, 464. The port 406, 408 comprises a penetrable, resealable septum, and a needle stop may be included within the fluid chamber opposite the resealable septum to prevent needle perforation of the wall of the fluid chamber 470.

The S-shaped chamber housing 472 enclosing the fluid chamber 470 is shaped with opposed spiral arms 466 and 468 respectively coupled to sling intermediate end 36, 46 and end 38, 48. The housing 472 is formed of a material that is expandable as fluid volume and pressure increases as shown in FIG. 39 and contractible as fluid volume and pressure decreases as shown in FIG. 40. The adjustment spacing 162, 164 is therefore adjusted by injecting or withdrawing fluid from the fluid chamber 470 to laterally extend or retract the opposed spiral arms 466 and 468 to increase or decrease the adjustment spacing 162,164 as shown in FIGS. 37-40.

In a further alternative variation (not shown), the arms 466 and 468 may be corrugated with one or more corrugation to function in the manner of bellows. In such case, the arms 466 and 468 may be spiral as depicted or extend in axial alignment and away from one another to increase or decrease the adjustable spacing 162, 164.

In certain further embodiments of the second category of the invention depicted schematically in FIG. 41, the sling tension adjustment mechanisms 502 and 504 comprise fluid reservoirs 512 and 514, housings 522 and 524, respectively, and tubes 532 and 534 extending between the fluid reservoirs 512 and 514 and housings 522 and 524, respectively, alongside the sling end portions 42 and 44, respectively. The housings 522 and 524 are coupled to the sling intermediate ends 36, 38 and 46, 48, respectively, and define the adjustment spacings 162 and 164, respectively.

The fluid reservoirs 512 and 514 are adapted to be implanted just below the skin 52 adjacent the skin incisions 82 and 84, respectively. Alternatively, the tubes 532 and 534 may extend through the skin incisions 82 and 84 to dispose the fluid reservoirs 512 and 514 outside the skin during the healing phase. In that case, the tubes 532 and 534 may be pulled upon to detach their distal ends from tube fittings on the housings 522 and 524 after tissue ingrowth into the mesh pores has secured the sling 20 in position. Tissue ingrowth should maintain the adjustment spacings 162, 164 even if the hydraulic fluid (saline) then escapes from fluid cylinders and chambers within the housings 522 and 524.

The fluid reservoirs 512 and 514 have respective fluid delivery/withdrawal ports 516 and 518 that may be percutaneously accessed by needle tip 412 of syringe 410 to introduce fluid into the fluid reservoir 512, 514 or to withdraw fluid from the fluid reservoir 512, 514 following implantation of the sling 20 to thereby adjust the amount of fluid in the fluid chambers of housings 522 and 524 and adjust the length of the adjustable spacings 162 and 164.

It will be understood that the housings 522, 524 may incorporate any of the adjustment mechanisms 402, 404 or 432, 434 or 462, 464 and variations thereof described above with the tubes 532, 534 and fluid reservoirs 512 and 514 substituted for the above-described fluid delivery/withdrawal ports.

In FIGS. 42-45, alternative forms of adjustment housings 522 and 524 of the adjustment mechanisms 502, 504 and 502′, 504′ containing fluid chambers, pistons, and connecting rods are depicted in greater detail. The housing 522, 524 encloses a fluid chamber 526, a piston 528 and a rod 530 extending axially from one end of the housing 522, 524. In the particular single action cylinder designs depicted in FIGS. 42-45, the housing 522, 524 is elliptical in lateral cross-section having a major ellipse axis corresponding generally to the width of the mesh 30 of sling 20 so that the minor ellipse axis minimizes overall thickness of the sling 20. The housing wall 542, fluid chamber 526, and piston 528 may be shaped more oblong than elliptic as shown in FIG. 46. The sling intermediate end 36, 46 is coupled by thermoplastic rivets or sutures or the like to the stationary end of housing 522, 524, and the sling intermediate end 38, 48 is coupled by thermoplastic rivets or sutures or the like to the movable free end of rod 530 in each housing 522, 524. It will be understood that the piston 528 is formed with a ring or rings that provide a tight seal with the housing wall 542 defining the fluid chamber 526 to minimize fluid loss.

In the variation of this embodiment of adjustment mechanism 502, 504 depicted in FIGS. 42-44, the tubes 532 and 534 extend from the end of the housing 522, 524 opposite the rod 530 and centrally along the axes of the mesh 30 of each of the end portions 42 and 44, respectively, to the fluid reservoirs 512 and 514, respectively, to supply fluid to or withdraw fluid from the chamber portion defined by the housing interior wall 536 and the piston head 538. In the variation of adjustment mechanism 502′, 504′ depicted in FIG. 45, the tube 532, 534 extends offset from the axis of the sling mesh 30.

A dual action hydraulic cylinder form of an adjustment mechanism 552 similar to adjustment mechanisms 502, 504 and 502′, 504′ is depicted in FIG. 46. An oblong shape of the piston 558, the housing 562, and fluid chamber 556 is also depicted in FIG. 46 that may be substituted for the elliptical shapes of the piston 528, housing 522, 524, and fluid chamber 526, respectively, of FIGS. 42-45.

The dual action adjustment mechanism 552 requires two subcutaneously implantable fluid reservoirs (not shown) or a dual action fluid reservoir and tubes 572 and 574 extending alongside the sling mesh to subcutaneous implantation sites. The housing 562 encloses a fluid chamber 556, piston 558 and rod 560 extending through an opening in one end of the housing 562. The fluid chamber 556 comprises a contracting chamber 568 Coupled to tube 572 on one side of piston 558 and an extending chamber 570 coupled to tube 574 on the other side of the piston 558.

In use, the adjustment mechanism 552 is substituted for the adjustment mechanisms 502 and 504 of FIG. 41 to define the adjustment spacings 162 and 164 as a function of the position of the piston 558 in the fluid chamber 556. The adjustment spacing 162, 164 is lengthened if fluid is introduced into chamber portion 570 from the first fluid reservoir through tube 574 while fluid is simultaneously withdrawn from chamber portion 568 into the second fluid reservoir through tube 572. Conversely, adjustment spacing 162, 164 is shortened if fluid is introduced into chamber portion 568 from the second fluid reservoir through tube 572 while fluid is simultaneously withdrawn from chamber portion 570 into the first fluid reservoir through tube 574.

Any of the above-described single action hydraulic adjustment mechanisms can be modified in this fashion to function as a dual action hydraulic adjustment mechanism. It may be desirable to provide a locking mechanism to maintain the adjusted position of the piston and rod of the single or dual action hydraulic adjustment mechanisms disclosed herein after setting the adjustment spacing. Leakage and blow-by of the pressurized hydraulic fluid may occur causing the adjustment spacing to change before tissue ingrowth into the sling mesh pores stabilizes the sling.

FIGS. 47 and 48 illustrate one form of locking mechanism 405 incorporated into a single action hydraulic cylinder adjustment mechanism 402, 404 of the type shown in FIGS. 28-31. In the depicted single action, hydraulic cylinder, adjustment mechanism 402′, 404′, upper and lower lines of serrations or teeth 421 and 423 extend along the rod 420. The rod 420 extends from the cylinder 455 within housing 422 and passes through a locking ring 425 mounted to slightly rock or pivot on axle 427 supported by the outer housing 415. A counterweight rod 429 also extends from the axle within the outer housing 415. Serrations or teeth are also formed on the inner wall of the locking ring 425 in alignment and engagement with the upper and lower lines of serrations or teeth 421 and 423.

The frictional engagement of the serrations of the locking ring 425 and the upper and lower lines of serrations or teeth 421 and 423 function as the locking mechanism 405 and tend to inhibit movement of the rod 420, but the engagement force is overcome when fluid is added to or removed from the cylinder. The piston and rod 420 can therefore move between its limits due to the change in fluid pressure. If fluid pressure gradually decreases due to leakage, the counterweight rod 429 tends to cause the locking ring 425 to pivot on axle 427 to engage the teeth together to resist movement of the rod 420. It will be understood that the outer housing 415 may extend completely around the locking ring 425 and the housing 422 to isolate them from body tissue.

FIGS. 49 and 50 illustrate another form of locking mechanism 435 incorporated into a single action hydraulic cylinder adjustment mechanism 402, 404 of the type shown in FIGS. 28-31. In the depicted single action hydraulic cylinder adjustment mechanism 402″, 404″, the locking mechanism 435 comprises modifications to the rod 420 providing reduced diameter sections 437, 439, and a laterally extending pin 441, a pair of springs 447, 449 disposed around rod sections 437, 439, and a rotatable sleeve 457 disposed over the rod 420. The rotatable sleeve 457 surrounding rod 420 extends through the C-shaped opening 417 in housing 415. A spiral slot 451 with a plurality of notches 453 is formed in the rotatable sleeve 457, and the pin 441 extends through the spiral slot 451 and can be engaged in a notch 453.

The adjustment spacing 162, 164 is adjusted by injecting or withdrawing fluid from the fluid chamber to laterally extend or retract the piston mounted rod 420 to increase or decrease the adjustment spacing 162, 164. In the process, rod 420 is moved within cylinder 455 against the spring force of one or the other of the springs 447, 449 and the outwardly extending pin 441 travels along the spiral slot 447, rotating the sleeve 457. The spring force functions as a detent by lodging the pin 441 into engagement with the closest notch 453. The engagement resists any change in rod position that might otherwise occur due to loss of fluid from the cylinder. However, the engagement force can be overcome when fluid is added to or removed from the cylinder. It will be understood that the outer housing 415 may extend completely around the pin 441 and the housing 422 to isolate them from body tissue.

These locking mechanisms may be incorporated into the various single and dual action hydraulic cylinder adjustment mechanisms disclosed herein.

A further miniaturized single action hydraulic cylinder adjustment mechanism 402″, 404″ is depicted in FIGS. 51-53 that may be substituted for the above-described adjustment mechanism 502, 504 of FIG. 41. In this embodiment, the width and height or diameter of the modified housing 415′ is sized to correspond generally to the width of the sling mesh 30 of sling 20. The locking mechanism 405 described above is incorporated into the modified housing 415′ although locking mechanism 435 may be substituted for locking mechanism 405. The cylinder 455 is directly coupled to a tube coupling 419 that the end of the tube 532, 534 is affixed to. The syringe 410 is employed to penetrate the septum of the fill port 512, 514 to add or remove fluid from cylinder 455 and adjust the rod 420 to adjust the adjustable spacing as described above with respect to FIG. 41. As noted above, the tube distal end may be detached from the fluid coupling 419 when tissue ingrowth immobilizes the sling mesh 30. It will be understood that the outer housing 415′ may extend completely around the locking ring 425 and the housing 422′ to isolate them from body tissue.

The adjustable mechanism of the second aspect of the sling 20 of the present invention may also comprise miniaturized mechanical mechanisms that are adjustable outside the patient's skin or percutaneously through the patient's skin during the healing phase. In certain embodiments the external adjustment actuator comprises an elongated gear drive instrument having a shaft extending between a handle and an engaging end shaped to be percutaneously advanced through the skin. The adjustment mechanism comprises a driven gear means engageable by the engaging end the gear drive for operating the spacing adjustment means to increase or decrease the adjustment spacing.

A miniaturized gear driven adjustment mechanism 802, 804 is depicted in FIGS. 54 and 55 that may be substituted for the above-described adjustment mechanisms 502 and 504 of FIG. 41. An adjustment mechanism housing 822 is attached at one end to the intermediate sling end 36, 46 and encloses a gear chamber 826 and a rod chamber 824. A driven gear 828 is enclosed within the gear chamber 826, and a rod 820 having a spiral thread 834 extending around its circumference extends through the rod chamber 824 and out of housing end opening 832. The spiral thread 834 engages gear threads within the bore of the driven gear 828. One end of the rod 820 is coupled to the intermediate sling end 38, 48.

A gear drive 810 comprises an elongated drive shaft 812 extending through a sheath lumen 814 of a drive sheath 816 to a drive gear 830 within the gear chamber 826 of an outer housing 822. The teeth of the drive gear 830 and the driven gear 828 are in engagement. The drive sheath 816 extends through the skin incisions following implantation to enable adjustment of the length of the rod 820 within the rod chamber 824. The gear drive handle 818 may be grasped and rotated to rotate the drive shaft 812 and the drive gear 830. Rotation of the driven gear 828 around the rod 820 in one direction drives the rod 820 out of the rod chamber 824 and lengthens the adjustment spacing 164, 166, whereas rotation of the driven gear 828 around the rod 820 in the other direction drives the rod 820 into the rod chamber 824 and shortens the adjustment spacing 164, 166.

The distal end of drive shaft 812 may be shaped to detachably engage axially with the drive gear 830 so that the drive sheath 816 and shaft 812 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 822 and drive gear 830, respectively, and be drawn out through the skin incision after tissue ingrowth into the mesh pores has secured the sling 20 in position.

An alternative, miniaturized, gear driven adjustment mechanism 852, 854 is depicted in FIG. 56 that may be substituted for the above-described adjustment mechanisms 302 and 304 of FIG. 18. An adjustment mechanism housing 872 is attached at one end to the intermediate sling end 36, 46 and encloses a gear chamber 876 and a rod chamber 874. A driven gear 878 is enclosed within the gear chamber 876, and a rod 870 having a spiral thread 884 extending around its circumference extends through the rod chamber 874 and out of housing end opening 832. The spiral thread 884 engages gear threads within the bore of the driven gear 878. One end of the rod 870 is coupled to the intermediate sling end 38, 48.

A gear driver 860 comprises an elongated drive shaft 866 having a spiral drive gear 880 at the distal end of the drive shaft 866 and a handle 868 at the proximal end of the drive shaft 866. The distal end of the gear drive 860 may be shaped to be percutaneously advanced through the patient's intact skin at pre-made incisions to interact with the driven gear 878. The distal end of the drive shaft 866 is extended through an opening in the housing 872 and into engagement with the drive gear 880 to adjust of the length of the rod 870 within the rod chamber 874. The teeth of the drive gear 880 and the driven gear 878 are depicted in engagement in FIG. 56. The gear drive handle 868 may be grasped and rotated to rotate the drive shaft 866 and the drive gear 880. Rotation of the driven gear 878 around the rod 870 in one direction drives the rod 870 out of the rod chamber 874 and lengthens the adjustment spacing 164, 166, whereas rotation of the driven gear 878 around the rod 870 in the other direction drives the rod 870 into the rod chamber 874 and shortens the adjustment spacing 164, 166.

It will be understood that alternatively, the gear drive may take the form of gear drive 810 of FIG. 54 that is temporarily left extending through the skin incisions following implantation of the sling. In that case, the distal end of drive shaft 812 may be shaped to detachably engage axially with the drive gear 880 so that the drive sheath 816 and shaft 812 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 872 and drive gear 880, respectively, and be drawn out through the skin incision after tissue ingrowth into the mesh pores has secured the sling 20 in position.

A still further alternative, miniaturized, mechanical drive mechanism 902, 904 is depicted in FIG. 57 that may be substituted for the above-described adjustment mechanisms 502 and 504 of FIG. 41. In this embodiment, the adjustment spacing 164, 166 is adjusted by a rack and pinion gear drive 910 extended temporarily through the patient's skin or implanted under the patient's skin and accessed percutaneously with an external adjustment actuator 310 shaped to engage the pinion gear drive 910 similar to external adjustment actuator 31 0 shown in FIG. 18.

In the embodiment depicted in FIG. 57, the gear drive 910 comprises an elongated drive shaft 912 extending through a sheath lumen 914 of a drive sheath 916 from a gear drive housing 918 to the mechanical drive mechanism 902, 904. The proximal end of the sheath 916 is coupled to the gear drive housing 918. The gear drive housing 918 encloses a gear chamber 926 in which a rack 930, coupled at one end to the proximal end of the drive shaft 912, is disposed for lateral movement, and a pinion 928 is positioned for rotary movement. The teeth of the rack 930 and the pinion 928 are in engagement. A hex shaped recess 932 is formed in the pinion to be engaged by a hex wrench to rotate the pinion 928 and laterally move the rack 930 within the gear chamber 926.

The distal ends of the sheath 916 and the drive shaft 912 are coupled to one end of the housing 906 of the drive mechanism 902, 904. The housing 906 takes the form of the housing 415′ of FIGS. 51-53 and is depicted without a cover to expose the rod chamber 908 and the rod 920 and locking mechanism 905 disposed therein. Locking mechanism 905 corresponds to locking mechanism 405 described above and may take other forms or may not be provided in this embodiment.

Rotation of the pinion 928 in one direction drives the rack 930 and the drive shaft 912 in one direction to drive rod 920 out of the rod chamber 908 and lengthen the adjustment spacing 164, 166. Rotation of the pinion 928 in the other direction drives the rack 930 and the drive shaft 912 in the other direction to pull rod 920 into the rod chamber 908 and shortens the adjustment spacing 164, 166.

A still further alternative, miniaturized, mechanical drive mechanism 952, 954 is depicted in FIGS. 58A-58D that may be substituted for the above-described adjustment mechanisms 502 and 504 of FIG. 41. In this embodiment, the adjustment spacing 164, 166 is also adjusted by a rack and pinion gear drive 910 extended temporarily through the patient's skin or implanted under the patient's skin and accessed percutaneously with an external adjustment actuator 310 shaped to engage the rack and pinion gear drive 910 as described above with respect to FIG. 57.

In this embodiment, the housing 956 is coupled at one end to the sling intermediate end 36, 46, and encloses a rack chamber 958 and a driven rack 962 within the rack chamber 958. The driven rack 962 in rack chamber 958 is coupled at one rack end to the end of the drive shaft 914 and at the other rack end to the sling intermediate end 38, 48. A pivotally mounted catch 964 is shaped to engage rack teeth 962 and to guide movement and help maintain rack 960 in a selected position in the rack chamber 958 to define the adjustment spacing 162, 164.

Rotation of the pinion 928 in one direction drives the drive rack 930 and the drive shaft 912 in one direction to move drive rack 962 out of the rack chamber 958 and lengthen the adjustment spacing 164, 166 as shown in FIG. 58B. Rotation of the pinion 928 in the other direction moves the rack 930 and the drive shaft 912 in the other direction to pull rod 920 into the rack chamber 958 and shortens the adjustment spacing 164, 166, as shown in FIG. 58D.

It will be understood that the gear drive housing 918 can be implanted under the skin. It will also be understood that each gear drive housing 918 can be temporarily left extending through the skin incisions following implantation of the sling. In this case, the distal end of drive shaft 912 may be shaped to detachably engage axially with the rod 920, and the distal end of the sheath 916 may detachably engage with the end of the housing 906 or 956. After tissue ingrowth into the mesh pores has secured the sling 20 in position, the drive sheath 916 and shaft 912 may be axially pulled upon from their proximal ends outside the skin to detach from the housing 906 or 956 and rod 920 or rack 960, respectively, and be drawn out through the skin incision.

With respect to the embodiment of FIGS. 58A-58D, it will be understood that the drive pinion 928 can alternatively be integrated into the rack chamber 958 in lieu of or alongside the pivoting catch 964. In this variation, the gear drive 910, sheath 916, and the shaft 912 would be eliminated, and the pinion 928 located if the rack chamber 958 could be accessed by the percutaneously inserted hex wrench 310 in the manner described above with respect to FIGS. 18-23.

The embodiments of FIGS. 59A-59E show various sling tension adjustment mechanisms or assemblies 1002 including at least one piston member displaceable within a sling adjustment housing to control and adjust the tension or length of the sling.

The tension adjustment assembly 1002 includes a housing 1018 having an interior 1019 and an access opening 1020 that is used for injection and/or withdraw of fluid from the interior 1019. The housing 1018 can be manufactured from any biocompatible material such as silicone and the like. The housing 1018 can also be manufactured from Polyethylene Terephtalate (PET).

Continuing with the example embodiment of FIGS. 59A-59E, sling or sling arms 1014 can be coupled to the housing 1018. The sling arms 1014, e.g., 1014 a, 1014 b, can be connected to the sling directly or with an intermediate suture or like material or connection feature. Tension adjustment of the assembly can be accomplished by axial movement of a piston-shaped rod or plunger 1021 a (or 1028) within the interior 1019 of the housing 1018. The rod 1021 a can have an end that extends out of an opening in the housing 1018 and attaches to an end of one of the arms 1014. The rod or plunger 1021 can also include a plunger stopper portion 1028 a. Axial movement of the rod 1021 a moves the connected arm 1014 closer to or further away from the housing 1012, thereby, adjusting an overall tension of the support. Other configurations are also possible and should be considered to be within the spirit and scope of the invention. For example, one of the arms 1014 can be coupled to the rod 1021 a in a manner that permits the arm 1014 to move generally parallel to a longitudinal axis of the housing 1018.

In one example embodiment, as shown in FIG. 59E, the rod 1021 a has a size and shape that generally fills a cross section of the interior 1019 of the housing 1018. The rod 1021 a can also have a seal portion 1021 b that engages an inner surface of the housing 1018 and prevents fluid injected in or stored in the housing 1018 from flowing into a portion of the housing 1018 closest distal the fluid opening 1020. The seal portion 1021 b can also aid in facilitating a smooth or controlled axial movement of the rod 1021 a within the housing 1018. The seal portion 1021 b can be a similar or dissimilar material to the rod 1021 a and can take on various shapes, sizes and configurations.

In another example embodiment of the invention, as illustrated in FIG. 59D, housing 1018 has a balloon or bladder 1024 operatively disposed in the interior 1019 of the housing 1018. The bladder 1024 can be in fluid communication with tubing 1026 or other communication members extending from the housing 1018 and connected to a port, such as those described or depicted herein. The bladder 1024 can be inflated and deflated by injecting fluid into the port and through the tubing 1026. The bladder 1024 can be connected to or can engage a piston-like plunger 1028 that is also operatively disposed in the interior 1019 and connected to at least one of the arms 1014 or sutures associated therewith. The plunger 1028 can have a size and shape that generally fills a cross section of the interior 1019 of the housing 1018. When the bladder 1024 is inflated it can move the plunger 1028 toward one of the strap arms distal the bladder 1024 (e.g., toward arm 1014 a), which in turn causes the overall length of the sling support to lengthen. If the bladder 1024 is connected to the plunger 1028, the overall length of the sling support can be shortened by deflating the bladder 1024, which causes the plunger 1028 to move toward the arm 1014 b.

FIG. 59C shows another configuration for the tension adjustment assembly 1002. In this exemplary embodiment, plunger 1028 is connected to one of the arm portions 1014 of the sling. For instance, the plunger can be attached to the arm portion 1014 by at least one suture. The bladder 1024 is disposed in the interior 1019 of the housing 1018 and is positioned generally between an arm portion 1014 and the plunger 1028. As such, inflating the bladder 1024 causes it to expand, thereby engaging and moving the plunger 1028 towards the arm portion 1014 b, which causes the overall length of the sling support to shorten. An inlet 1026 is in fluid communication with the bladder 1024 to control inflation and deflation of the bladder 1024 and, in turn, movement of the plunger 1028 within the interior 1019. The inlet 1026 can run out the housing 1018 at any portion thereof, or traverse along or through one of more of the arms 1014. In this embodiment, the plunger 1028 can be constructed of a rigid, semi-rigid, or flexible material. For instance, in one embodiment, the plunger 1028 can be constructed of a desired material, such as suture material, to encase, or at least partially contain the bladder 1024 and allow for flex during inflation and deflation. In such an embodiment, the plunger end portion or stopper 1028 a can be rigid or semi-rigid, or even relatively flexible.

The bladder 1024 can be manufactured from any material such as nylon, PEBAX, PET, PE, Polyurethane, PVC, or other similar materials. One skilled in the art will be able to ascertain the various materials capable of providing the functionality needed to adjust the bladder 1024, provide expansion and contraction capable of moving the plunger 1028, and providing length adjustment of the sling and sling support system.

In other embodiments, one or more bladders 1024 can be included in the housing 1018, or separately without a housing, and without a corresponding plunger or piston device. The bladders 1024 can alone provide the desired adjustability to comprise the tension adjustment assembly or mechanism to operatively connect with the sling to selectively adjust the sling length. The bladders 1024 can be included in an overlapped, serial, or adjacent configuration, or like configurations and designs to provide selective inflation and deflation of the respective bladders 1024 to control the sling length.

In any of the embodiments it is also possible to include a biasing member (not shown), such as a coil, spring, or shape memory member, between an inner surface of the housing 1018 and the plunger 1028. Such a member can provide predetermined resistance to better provide control over the movement, positioning and precision displacement of the plunger 1028 to adjust the length and tension of the sling support system.

It is also envisioned that the present invention may include a locking mechanism (not shown) incorporated into or at least partially operatively disposed in the interior 1019 of the housing 1018 that could be used to selectively lock or fix the plunger 1028 in a particular location. The locking mechanism could comprise a ratchet, movable pin, cam and the like, that retains the position of the plunger 1028 without relying on the hydraulic fluid/pressure. Once in the desired location, the locking mechanism retains the plunger or rod 1028 in position. In the case of fluid or pressure loss, the rod or plunger will remain in its locked position. In an alternative embodiment, once the rod or plunger is in the desired position, the fluid can be removed. If there is a need to further increase the tension, fluid can be reintroduced or added to move the rod or plunger.

The embodiments of FIGS. 60A-60R show various sling tension adjustment mechanisms or assemblies 1030 generally including one or more set screw and/or bobbin assemblies to control and adjust the tension or length of the sling. Further, certain embodiments depict various structures and techniques for selectively locking the bobbin in place, e.g., limit or restrict rotational displacement of the bobbin.

Referring generally to FIG. 60A, an adjustment assembly 1030 is provided with a screw or turnable adjustment slot 1032. The adjustment slot 1032 can be included at any portion of housing 1034, and in operable communication with an internal bobbin or spool 1036, or other like device adapted to control and adjust coiled or wrapped material, such as a tension suture 1038. An adjustment tool 1045 is configured to mate with the adjustment slot 1032, or other portions of the housing 1034 or internal components of the housing, to provide rotatable restriction or adjustment of internal components or structures within the housing 1034 to control sling tension or length.

FIG. 60B shows an embodiment of the present invention having a set screw adjustment member 1040. The set screw 1040 can be provided in any portion of the housing 1034, with or without the adjustment slot 1032. As detailed further herein, the set screw 1040 is generally used to selectively adjust an internal assembly or component within the housing 1034 to lengthen or shorten the sling length, and thus adjust the sling support portion.

As depicted in FIGS. 60C-60D, the housing 1034 can include one or more indexing slots 1044. The indexing slots 1044 are generally mateable with corresponding prongs or members 1046 of the adjustment tool 1045. As such, the inner shaft 1045 a of tool 1045 centrally engages the adjustment slot 1032, while the peripheral prongs 1046 engage the indexing slots 1044. The inner shaft 1045 a is capable of independent rotation within the tool 1045. Accordingly, such a configuration facilitates stable rotation or manipulation of the tool 1045, including single-handed manipulation. The tool 1045 is keyed into the slots 1044 of the housing 1034 via the prongs 1046 and the inner shaft 1045 a can be independently rotated or manipulated to adjust a set screw or other adjustment mechanism at the adjustment slot 1032.

FIGS. 60A-60I depict various adjustment assembly embodiments including the suture bobbin and/or set screw devices configured to provide selective adjustability of the sling support. In general, a bobbin or spool device 1050 is disposed within the housing 1034, with a length of suture 1052 wrapped or coiled around a central portion 1050 a. The suture 1052 is capable of adjustable deployment onto and unwinding from the bobbin device 1050. The bobbin device 1050 can be operably rotatable within the housing 1034 to facilitate adjustment of the length of the suture 1052. The suture 1052 extends out from the central portion 1050 a to attach or otherwise connect, directly or indirectly, to the sling. Any of the depicted and described bobbin devices 1050 can include one or more flange portions extending therefrom, but may be shown in certain embodiments with only a top flange for illustrative purposes.

As depicted in FIGS. 60A-60F, threadable adjustment of the set screw 1054 into contact with an engagement portion 1050 b of the bobbin device 1050 restricts movement (e.g., unwinding) of the bobbin device 1050. This, in turn, limits deployment or uncoiling of the suture 1052 from the central portion 1050 a of the bobbin device 1040. When adjustment of the sling or support length is desired, the set screw 1054 can be threadably adjusted away from the engagement or flange portion 1050 b of the bobbin device 1050 such that the suture 1052 can be unwound or uncoiled to increase the length of the sling. Upon obtaining the desired sling length, the set screw 1054 can once again be brought into contact with the bobbin device 1050 to restrict the bobbin device 1050 and thus restrict length adjustment. An adjustment tool, such as those described herein, in operable (e.g., rotatable) communication with the bobbin device 1050 can be employed to control winding onto or unwinding the suture 1052 from around the central portion 1050 b of the bobbin 1050.

In the embodiments of FIGS. 60G-60I, the bobbin adjustment mechanism or assembly 1030 can include a selectively positionable ball and detent system to control the rotation of the bobbin 1050, and thus the length of the suture 1052 winding onto or unwinding from the bobbin 1050. In one embodiment, as shown in the FIG. 60G, a biasing member or device 1060 (e.g., spring device) operably extends into the housing 1034. The end of the spring member 1060 can include a ball 1062, or rounded end portion, adapted and sized to rest in corresponding detents 1064 in the engagement portion 1050 b of the bobbin 1050. The engagement portion 1050 b can include a plurality of detents 1064, as depicted in FIG. 60I. As such, the spring member 1060 biases the ball 1062 into a proximate detent 1064 to provide additional resistance to movement (e.g., unwinding) of the bobbin 1050. The level, frequency and precision of the resistance can be controlled by altering the configuration of the detents, spring tension, and the like. Moreover, multiple detents 1064 provide discrete or predefined locking points upon rotation (winding or unwinding) of the bobbin 1050. In the embodiment of FIG. 60H, the detents 1064 are provided in a tapered or ramp-like configuration. As such, loosening and tightening of the bobbin 1050 is met with variable resistance and travel. In each of the embodiments described, an adjustment tool 1045, or other known tools, can be used to torque the bobbin 1050 to facilitate loosening and tightening of the bobbin 1050 and any corresponding suture attached thereto. This feature provides selective locking or restriction of the bobbin to control suture and sling length, as well as movement.

Additionally, a variation on the embodiments of FIGS. 60G-60I is depicted in FIG. 60J. In one exemplary embodiment, the engagement portion 1050 b of the bobbin 1050 can include peripherally extending cogs or teeth that define a detent gap therebetween, and a moveable or displaceable ball or member 1072 sized and configured to selectively slide and rest between adjacent teeth 1070. As such, segmented or distinct precision restriction of the bobbin 1050 is provided. Each of the components can be included within housing 1034, and in operable communication with adjustment devices or tools to control the resistance to rotation of the bobbin 1050.

FIGS. 60K-60L show various embodiments of another bobbin device 1050 for the sling adjustment assembly or mechanism. Like the other embodiments, the bobbin 1050 is provided within the housing 1034, and a suture is wrapped around the bobbin 1050 for attachment, directly or indirectly, to a sling 30. The bobbin 1050 can include an internal channel or passageway 1078 adapted to receive a positionable tumbler 1080 and/or an adjustment tool 1045. The tumbler 1080 can be shaped or sized in such a way that it restricts rotation of the bobbin 1050 when the tumbler is positioned within the bobbin channel 1078. Feature such as protrusions, tapering or other configuration can be included with the tumbler 1080 as well to restrict rotation of the bobbin 1050.

The housing 1034 further includes a recess or channel 1082 alignable with the channel 1078 of the bobbin 1050. A biasing member 1084, such as a spring, can be included within the housing recess 1082. As such, the tumbler 1080 can be disposed within the bobbin channel 1078 and/or the housing recess 1082, with the biasing member 1084 urging the tumbler 1080 upward or out of the recess 1082. FIG. 60 k depicts the adjustment bobbin in a neutral position, where the tumbler 1080 is at least partially disposed within the bobbin channel 1078 and partially within the housing recess 1082. In this neutral position, the tumbler 1080 restricts the rotation of the bobbin 1050, and thus the movement of the suture and sling. FIG. 60L depicts the bobbin assembly in a disengaged position. To obtain this position, a shaft of a tool 1045 or device can be inserted through the bobbin channel 1078 down into contact with the tumbler 1080. Sufficient force down on the tumbler 1080 compresses the spring 1084, thereby disengaging or moving the tumbler 1080 from its rotational restricting position within the channel 1078. As such, the bobbin 1050 is free to rotate, permitting unwinding of the suture from the bobbin to adjust the suture and sling length. After adjustments are made to the suture length, e.g., unwinding a length from the bobbin, the tool 1045 is withdrawn, thereby permitting the tumbler 1080 to reenter the bobbin channel 1078 under the bias of the biasing member or spring 1084 such that the bobbin 1050 is again locked or retained in place.

FIGS. 60M-60N depict embodiments of the bobbin adjustment assembly having additional plates, washers, and/or other structures within the housing 1034 to control or restrict unwinding of the suture 1052 from the bobbin 1050. The components of this embodiment are generally exaggerated spatially and proportionally in the corresponding figures for illustrative purposes only. In the embodiment of FIG. 60M, a conical washer 1087 and a spacer plate 1088 are included between the bobbin 1050 and an interior surface of the housing 1034 to selectively pinch or contain the suture 1052. In the embodiment of FIG. 60N, a conical washer 1087 is provided below the bobbin 1050. In both embodiments, and variations thereof, the suture 1052 is wound around the bobbin 1050, with a portion of the suture 1052 extending back onto a top or bottom surface (e.g., flange 1050 b) of the bobbin 1050. The washers 1087 and/or plates 1088, or like structures or members, provide a spring-like feature to selectively pinch the suture 1052 when restriction on unwinding the suture 1052 is desired. As such, the suture and sling length can be adjusted, and then the suture is pinched, automatically or manually, between the structures to restrict unwinding from the bobbin 1050.

In FIGS. 60O-60R, various embodiments of the bobbin adjustment assembly are depicted. The bobbin device 1050 is disposed within the housing 1034, with a length of suture 1052 wrapped or coiled around a central portion 1050 a. The bobbin device 1050 can, like all of the other bobbin devices disclosed herein, include one or flange portions 1050 b. Further, the housing 1034 can include a resting or securement portion 1034 a adapted to receive or secure portion of the bobbin device 1050. This portion 1034 a can also be included in any of the bobbin or suture embodiments disclosed herein.

The suture 1052 is capable of adjustable deployment onto and unwinding from the bobbin device 1050. The bobbin device 1050 can be operably rotatable within the housing 1034 to facilitate adjustment of the length of the suture 1052. In these embodiments, a portion of the suture 1052 is pinched or retained within the housing by a flange of the bobbin, or by another member in operable communication with the bobbin 1050. Certain embodiments, such as those shown in FIGS. 60Q-60R, can include a spring-activated retention feature. Namely, the embodiment of FIG. 60Q includes a resilient or spring-like member 1099 extending out from the bobbin 1050. This member 1099 is biased toward at least one wall of the housing 1034 such that the suture 1052 is retained between the member 1099 and the housing 1034. Manual force, or an adjustment tool or device, can be employed to selectively release or pull a length of the suture 1052 from the bobbin 1050. In the neutral or rested state, the member 1099 will again cause the suture 1052 to be pinched. The assembly of FIG. 60R can include a spring device 1092 attached to the housing 1034, directly or indirectly, such that a biasing force is directed toward a portion of the bobbin 1050 and suture 1052 to pinch or retain the suture 1052 in place. Again, manual or tool adjustment can be employed to selectively loosen or release a length of the suture 1052 from the bobbin 1050.

The embodiment of FIG. 60P includes a bobbin and suture assembly including one or more suture apertures 1096 in the housing 1034, and at least one bobbin aperture 1098 in a portion of the bobbin 1050 (e.g., the bobbin flange 1050 b). The apertures 1096 provide entry and exit ports in the housing 1034 for the suture 1052. As such, the suture 1052 is wrapped around the bobbin 1050, through the bobbin aperture 1098, with respective ends of the suture 1052 extending out the suture apertures 1096. As a result of this configuration, the suture 1052 can be pinched between the interior housing wall and the bobbin flange 1050 b to selectively control unwinding of the suture 1052 to control the sling length.

Various embodiments, including the embodiment of FIG. 600, can include a biasing member 1099, such as a spring, provided within a portion of the housing 1034 to exert a biasing force against the bobbin 1050, urging the bobbin 1050 and its flange 1050 b toward an interior wall of the housing 1034. This biasing force will generally pinch the suture 1052 between the flange 1050 b and the housing 1034. To selectively release the suture 1052 from this retained position, the bobbin 1050 can be forced down against the bias of the biasing member 1099 to release the suture 1052 for unwinding. The release force on the bobbin 1050 can be achieved using an adjustment tool, or other like devices or techniques. When a desired length of suture 1052 is unwound from the bobbin 1050, the bobbin 1050 can be released such that biasing force of the member 1099 again forces the flange 1050 b toward the housing wall to pinch the suture 1052 therebetween.

It will be understood that the above-described embodiments of the second category of the sling of the invention may be modified by substituting other support materials than open pore mesh 30, particularly in the central support portion 40, e.g., homograft or allograft materials or nonporous synthetic materials. Moreover, other materials and structures may be substituted for the mesh 30 in the sections constituting one or both of the end portions extending from the intermediate ends 38 and 48 to the ends of the central support portion 40. For example, one or more straight or spiral suture may be substituted for all or part of such sections.

While the above-described embodiments of adjustable tension slings depict methods and apparatus for adjusting sling tension in each end portion, it will be understood that in each case only one adjustment mechanism may be provided acting on or within one sling end portion (or alternatively on both end portions 1).

It will also be understood that all of the above-described embodiments of the urethral or fecal slings may optionally incorporate a sling central portion adjustment mechanism, e.g., suture 108 illustrated in FIGS. 10 and 11 or as otherwise described herein.

Furthermore, it will be understood that all of the above-described embodiments of the urethral or fecal slings illustrated in FIGS. 12 through 58 may optionally incorporate tissue anchors coupled to the sling ends extending from or incorporated into the sling ends 32 and 34. For example the sling anchor 92 illustrated extending from sling end 32 in FIG. 11 could be incorporated into a suture extending from the sling ends 32 and 34 in each such embodiment to assist in tensioning the sling end portions 42 and 44 during adjustment of the tension adjustment mechanisms.

Many of the embodiments described herein can be used in connection with prolapse and pelvic floor repairs (men and women) that may require post-operative adjustment of the implanted mesh or graft or sling. They may also be used in connection with prostatectomies or hysterectomies and to support any other body tissue within the pelvic area or other parts of the body including but not limited to, hernia repair, and shoulder and abdominal repairs. Examples of meshes, grafts, adjustable suture system and/or prolapse repairs are described in U.S. Publication Nos. 2004-0039453 A1, 2005-0250977 A1, and 2005-0245787 A1, and U.S. Pat. No. 4,969,892, each of which are hereby incorporated by reference in their entirety.

All patents and publications referenced herein are hereby incorporated by reference in their entireties.

It will be understood that certain of the above-described structures, functions and operations of the above-described preferred embodiments are not necessary to practice the present invention and are included in the description simply for completeness of an exemplary embodiment or embodiments. It will also be understood that there may be other structures, functions and operations ancillary to the typical surgical procedures that are not disclosed and are not necessary to the practice of the present invention.

In addition, it will be understood that specifically described structures, functions and operations set forth in the above-referenced patents can be practiced in conjunction with the present invention, but they are not essential to its practice. It is therefore to be understood, that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described without actually departing from the spirit and scope of the present invention.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4969892 *Mar 9, 1990Nov 13, 1990Ams, Inc.Suturing anchoring device for use in a female suspension procedure
US20030065402 *Oct 30, 2001Apr 3, 2003Ameican Medical SystemsImplantable article
US20030111507 *Dec 14, 2001Jun 19, 2003George NunezBalloon actuator for use in a resectioning device
US20040002726 *Jun 28, 2002Jan 1, 2004George NunezBalloon-type actuator for surgical applications
US20040230206 *Feb 9, 2004Nov 18, 2004Scimed Life Systems, Inc.Devices for minimally invasive pelvic surgery
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8170686 *Mar 14, 2006May 1, 2012Boston Scientific Scimed, Inc.Heatable sling support for an anatomical location
US8172745 *Feb 11, 2009May 8, 2012Ams Research CorporationTreatment of anal incontinence and defecatory dysfunction
US8449447Jul 14, 2010May 28, 2013Ams Research CorporationSystem and method for treatment of anal incontinence and pelvic organ prolapse
US8535217Jul 25, 2006Sep 17, 2013Ams Research CorporationMethods and systems for treatment of prolapse
US8678991Apr 3, 2012Mar 25, 2014Ams Research CorporationSystem for treatment of anal incontinence
US8678996Nov 29, 2012Mar 25, 2014Coloplast A/SIncontinence treatment device including non-porous sub-urethral sling
US8758218Apr 23, 2012Jun 24, 2014Coloplast A/SMethod of treating incontinence and treatment device including non-porous cuff and extending members
US8852076Mar 20, 2013Oct 7, 2014Ams Research CorporationSystem and method for treatment of anal incontinence and pelvic organ prolapse
US8926497 *Jan 16, 2014Jan 6, 2015Coloplast A/SIncontinence treatment device including non-porous sub-urethral sling
US9060839Sep 13, 2013Jun 23, 2015Ams Research CorporationMethods and systems for treatment of prolapse
US9084664May 21, 2007Jul 21, 2015Ams Research CorporationMethod and articles for treatment of stress urinary incontinence
US9089393 *Mar 28, 2012Jul 28, 2015Ams Research CorporationImplants, tools, and methods for treatment of pelvic conditions
US20110015474 *Jan 20, 2011Teslux Holding S.A.Vaginal operation method for the treatment of anal incontinence in women
US20110054244 *Sep 2, 2009Mar 3, 2011Bandula WijayAdjustable device for the treatment of female urinary incontinence
US20120016182 *Jan 19, 2012Ams Research CorporationFold-Resistant Pelvic Implant System and Method
US20120232573 *Mar 9, 2012Sep 13, 2012Boston Scientific Scimed, Inc.multi-arm inside-out tool for delivering implants and methods thereof
US20120253106 *Mar 28, 2012Oct 4, 2012Khamis Chaouki AImplants, tools, and methods for treatment of pelvic conditions
US20130053688 *May 13, 2011Feb 28, 2013Ams Research CorporationImplantable mechanical support
US20130079586 *Mar 30, 2012Mar 28, 2013Ams Research CorporationExpandable Implant System
US20130096371 *Apr 18, 2013Ams Research CorporationPelvic Implant Sizing Systems and Methods
US20140128665 *Jan 16, 2014May 8, 2014Coloplast A/SIncontinence treatment device including non-porous sub-urethral sling
US20140166514 *Mar 15, 2013Jun 19, 2014Ethicon Endo-Surgery, Inc.Packaging for Surgical Needle Cartridge and Suture
DE202012006023U1 *Jun 22, 2012Oct 15, 2013Feg Textiltechnik Forschungs- Und Entwicklungsgesellschaft MbhBandartige Strukturen zur Augmentation eines Ligaments
EP2659859A1 *May 1, 2013Nov 6, 2013Coloplast A/SIncontinence treatment device including non-porous sub-urethral sling
EP2691047A4 *Feb 28, 2012Mar 4, 2015Ams Res CorpImplants, tools, and methods for treatments of pelvic conditions
EP2739244A1 *Aug 3, 2012Jun 11, 2014AMS Research CorporationSystems, methods, and implants for treating prolapse or incontinence
EP2739244A4 *Aug 3, 2012Apr 8, 2015Ams Res CorpSystems, methods, and implants for treating prolapse or incontinence
Classifications
U.S. Classification600/30, 600/37
International ClassificationA61F2/02
Cooperative ClassificationA61F2250/0007, A61F2250/0002, A61F2/0045
European ClassificationA61F2/00B6B4
Legal Events
DateCodeEventDescription
Jun 30, 2009ASAssignment
Owner name: AMS RESEARCH CORPORATION, MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OGDAHL, JASON WESTRUM;LUND, ROBERT E.;ROLL, JESSICA L.;AND OTHERS;REEL/FRAME:022894/0052;SIGNING DATES FROM 20090520 TO 20090619
Jul 22, 2011ASAssignment
Owner name: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRA
Effective date: 20110617
Free format text: SECURITY AGREEMENT;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:026632/0535
Mar 3, 2014ASAssignment
Effective date: 20140228
Free format text: RELEASE OF PATENT SECURITY INTEREST;ASSIGNOR:MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVEAGENT;REEL/FRAME:032380/0053
Owner name: AMS RESEARCH CORPORATION, MINNESOTA
Mar 20, 2014ASAssignment
Free format text: GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:ENDO PHARMACEUTICALS SOLUTIONS, INC.;ENDO PHARMACEUTICALS, INC.;AMS RESEARCH CORPORATION;AND OTHERS;REEL/FRAME:032491/0440
Effective date: 20140228
Owner name: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AG